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Abstract 
DREW MILLETTE: Short-term Feeding Effects of High-Fat Diet on Hippocampal 
Neuroinflammation:  Differences among C57BL/6J, C3H/HeN, and C3H/HeJ mice 
(Under the direction of Dr. Patricia Sheridan) 
 
Neurodegenerative diseases represent a growing public health concern.  Increasing 
evidence has implicated a potential role of dietary intake of saturated fats in Alzheimer’s 
development, possibly through Toll-like Receptor 4 (TLR-4) activation in microglia.  We 
hypothesized that a diet high in saturated fats would increase neuroinflammation, and loss of 
TLR-4 would protect against this increase.  C57BL/6, C3H/HeN, and C3H/HeJ mice were 
given either a low-fat or a high-fat diet for 8 weeks.  HFD increased the expression of TNF- 
and decreased expression of IL-10 in the hippocampus of C57BL/6 mice, and increased 
microglial TLR-2 and TLR-4 receptors.  HFD did not increase neuroinflammation in 
C3H/HeN mice; however, IL-6, MIF and SOCS-3 transcription were decreased.  No 
differences were discovered in C3H/HeJ mice.  While microglia isolated from HFD-fed 
C3H/HeN mice had increased TLR-2 and TLR-4 expression, TNF-α was decreased 
following LPS-stimulation.  In conclusion, C57BL/6 mice are an appropriate model for short-
term HFD-induced hippocampal neuroinflammation. 
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Chapter I- Background 
Introduction 
Neurodegenerative disorders, such as Alzheimer’s disease (AD) represent a growing 
issue facing today’s population.  As compared to other leading causes of mortality, limited 
knowledge exists regarding risk factors and potential targets for treatment of 
neurodegenerative disease.  With advances in medical treatment of diseases such as 
cardiovascular disease, diabetes, and cancer, along with changes in the US age-distribution 
relating to the “baby boom” generation, a growing population over the age of 70 is at risk of 
AD development.  Emphasis on research in this field could lead to better overall health, 
longer lives, and could lessen the emotional and financial burden on families and the health 
care system [1]. 
Neurodegenerative diseases are characterized by loss of structure and function of 
neurons in various regions of the brain.  AD is a neurodegenerative disorder which results in 
neuronal death within the hippocampal and basal forebrain regions of the brain.  These neural 
regions are generally associated with learning, memory, and emotional states.  Cognitive 
impairment, short-term memory loss, and mood changes are all associated with the 
progression of the disease [1].  A main hallmark of AD is the formation of beta-amyloid 
plaques that are associated with neuronal death, and they are a predominant feature in brains 
of AD patients upon autopsy.  Other predictors of AD development include ventricular 
enlargement, hippocampal atrophy [2], tau protein alterations [3], cerebral amyloid 
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angiopathy, and silent cerebral infarcts [4].  Though these predictors for AD development 
have been discovered, both improving screening processes and discovering possible 
therapeutic targets for treatment remain main research focuses [5]. 
In order to develop new strategies for disease prevention and treatment of AD, it’s 
important to understand the underlying causative mechanisms driving AD etiology.  
Considering the complexity of the disease, discovering the underlying mechanisms requires a 
full understanding of specific risk factors that lead to increased AD development.  Our 
research focuses on the contribution of a high-fat diet, a modifiable risk factor, to potential 
mechanisms underlying the neurodegenerative disorder.     
Risk Factors of Alzheimer’s Disease Development 
Determining modifiable risk factors, such as nutritional variables, for AD 
development can be difficult given the long developmental period and complexity of the 
disease.  Many factors likely involved in increased AD risk have varying effects over a long 
time course.  Age is considered the predominant risk factor with AD prevalence drastically 
increasing as individuals age.  AD prevalence is quite common among individuals aged 70 
years, continues to increase in the 80 and 90 year age groups, and doubles every 5 years [6].   
Like many diseases, genetic components of AD have been proposed.  Early-onset 
AD, which represents only 0.01% of the total number of AD patients, has implicated roles of 
the amyloid precursor protein (APP) gene as well as presenilin-1 (PS-1) and presenilin-2 
(PS-2) genes.  These genes represent rare genetic influences that affect AD development in 
individuals under the age of 65[1,7].  A more common genetic influence in AD development 
resides in the apolipoprotein (APO) genes, specifically the ε4 gene polymorphisms within the 
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apolipoprotein E (APOE) gene variant.  Individuals with this allele have increased risk of 
developing the disease; however, this gene polymorphism, unlike those in APP or the 
presinilin genes, does not guarantee development of AD [7].  For most individuals, many 
lifestyle risk factors contribute to the development and progression of the disease. 
 Metabolic syndrome (MetS), a collection of associated risk factors that increase the 
risk for cardiovascular disease and type 2 diabetes mellitus has been implicated in several 
different ways in the pathogenesis of AD [8].  Vascular arterial disease has long been 
hypothesized to be closely related to Alzheimer’s development.  Dementia is characterized in 
many different ways including Alzheimer’s related dementia as well as non-Alzheimer’s 
related vascular dementia.  The vast majority of dementia cases lie between these two types 
[9].  Growing evidence suggests that pathologies of AD and vascular disease overlap and 
may be synergistic.  Preclinical determination of Alzheimer’s development is possible 
through measuring events of regional-specific cerebral perfusion, or the amount of blood 
flow in certain regions of the brain at a given time [10,11].  In addition, cerebral amyloid 
angiopathy, which is the accumulation of beta amyloid (Aβ) plaques in the arteries of the 
brain, is a characteristic of both stroke and Alzheimer’s, bridging the gap between the two 
diseases [4,10] . 
 Another aspect of MetS that has been implicated as a possible risk factor of AD 
development is hyperglycemia and insulin resistance in type 2 diabetes (T2D). Longitudinal 
studies have reported an association between insulin resistance, T2D, and AD [12,13].  
Dysfunctional insulin signaling has been linked to a number of detrimental consequences 
including oxidative stress, mitochondrial dysfunction, impaired membrane function, as well 
as increases in cellular glucose, cholesterol, acetylcholine, ATP levels, Aβ accumulation, and 
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tau hyperphosphorylation.  PET studies have demonstrated reduced glucose uptake in AD 
patients.  Hyperglycemia, as a result of impaired insulin signaling or insulin resistance, is 
associated with disruptive effects in the brain including detrimental effects on cognition and 
memory.  High levels of glucose in the brain are associated with formation of toxic 
advanced-glycation-end (AGE) products, reactive oxygen species (ROS), and 
hyperhomocysteinemia.  Hyperglycemia perfusing the brain may alter the cerebral vascular 
system, linking type 2 diabetes, vascular disease, and AD development [10,14]. 
 MetS is a collection of several related pathologies including abdominal obesity linked 
to an excess of visceral fat, insulin resistance, dyslipidemia, and hypertension [15].  
Pathologies associated with MetS may stimulate the development of Alzheimer’s disease.  A 
risk factor associated with developing MetS is obesity [16].  
Obesity and Alzheimer’s Disease 
 Obesity, a chronic condition characterized by the accumulation of excess adipose 
tissue, has been associated with increased risk of multiple morbidities, increased mortality, 
and it is a primary risk factor for both type 2 diabetes and cardiovascular disease.  Obesity 
represents a major, growing epidemic in the United States, with about two-thirds of the adult 
population being either overweight (body mass index (BMI) ≥ 25-30) or obese (BMI ≥ 30) 
[15].  In addition, obesity has been increasing world-wide with the spread of the Western 
Diet (WD).  The WD is characterized by higher levels of both dietary saturated fats and 
sugars [17].  In addition to its involvement in the Metabolic Syndrome, obesity, i.e. visceral 
fat expansion, has recently been proposed as a risk factor for the development of AD. In a 
study by Fitzpatrick et al. (2009), the authors reported that there was an increased risk of 
dementia in obese (BMI ≥ 30) vs. normal weight (BMI 20-25) individuals, after 
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adjusting for demographics (hazard ratio [HR], 1.39; 95% CI, 1.03 – 1.87).  Higher BMI in 
middle life has been reported to be associated with the development of cognitive impairment 
and possible neurodegeneration later in life [18].  Another epidemiological study, conducted 
by Xu et al. (2011), of a population-based twin study in relation to midlife BMI status, found 
that midlife, overweight BMI (25-30) and obesity (≥30) were associated with increased risk 
of dementia.  They used an adjusted generalized estimating equation with ORs of 1.71 (95% 
CI 1.30 – 2.25) for overweight and 3.88 (95% CI 2.12 – 7.11) for obesity [19].  
Determining associations between AD development and BMI can sometimes be 
difficult in older age groups, especially if low BMI in older age is an indicator of severe 
undernourishment.  A population-based prospective cohort study conducted by Hughes et al. 
(2009) as part of The Kame Project reported that subjects with higher baseline BMI and 
slower declining BMI in late life was associated with reduced risk of dementia.  The results 
of their study suggest that low BMI or a faster decline in BMI in late life may be preclinical 
indicators of the development of dementing illness, especially for those who were initially 
overweight or obese [20].   
Mouse Models of Obesity and Cognitive Impairment 
 Mouse models have also given indications that obesity impairs cognition.  These 
particular animal studies have utilized very long-term high-fat feeding models to induce 
obesity.  A study by Farr et al. (2008) tested diet-induced obese mice, as determined by 30% 
weight gain after 10 months of high-fat diet (HFD) feeding, against non-obese control mice 
in several spatial memory tests including the hippocampal-dependent Morris Water maze and 
the T-maze foot-shock avoidance tests.  Obese mice performed significantly less well than 
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non-obese mice in both of these spatial memory tests, indicating a relationship between 
obesity and hippocampal-dependent, cognitive impairment.  Farr et al. (2008) also reported 
that obese mice performed significantly less well in the non-hippocampal dependent, lever 
press test [21].  In a report, Hwang et al. (2009) presented evidence that obese male mice, fed 
a HFD for 9 to 12 months, had significantly lower long-term potentiation (LTP) than normal 
weight controls.  Long-term potentiation is a measure of synaptic plasticity and is important 
for retention of new memories.  Impairments in LTP are a characteristic of Alzheimer’s 
patients [22]. 
Saturated Fatty Acids, Cognitive Impairment, and AD development 
 Several studies investigated the effect of diet-induced obesity on AD development.  
However, in previous studies which had long dietary exposures [21,22], it was difficult to 
separate the effects of obesity from effects of the dietary components.  Diets high in saturated 
fatty acids have been proposed as a risk factor for AD development in humans and cognitive 
impairment in mice [23-25]. 
 Morris and co-investigators (2003) observed dietary influences of several types of 
fatty acids on later AD development in a population of Chicago inhabitants over the age 65 
with no pre-clinical AD symptoms observed.  After a mean follow-up of 3.9 years, the 
general trend indicated that diets high in saturated and trans-unsaturated fatty acids, as 
reported through a food-frequency questionnaire, correlated with increased risk of AD 
development in the subjects, whereas diets high in monounsaturated and ω-6 polyunsaturated 
fatty acids had a marginally decreased risk of AD development [23].  In another study, 
Mattson (2003) stated that low-calorie, low-fat diets have a protective effect against AD 
development in humans [1].   
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 Several mouse studies examined the effect of high-fat diets on cognition and possible 
risk factors for AD development [1,24,25].  By attempting to limit the consequences of HFD-
induced obesity; however, most studies were unable to fully separate short-term feeding 
effects of HFD from potential obesigenic effects on cognition.   
A study conducted by Gault et al. (2010) presented evidence that high fat diets result 
in cognitive impairment in object recognition tests.  In addition, Gault also presented 
evidence that high-fat fed mice have compromised LTP induction and maintenance as 
compared to low-fat fed controls [24].  The Mattson (2003) study reported HFDs promoted 
cognitive decline as compared to dietary restricted, low-fat controls in rodents [1].  Pistell et 
al.(2010) presented evidence that C57BL/6 mice fed high-fat diets consisting of 60% fat from 
lard for 16 weeks produced cognitive impairment and increased proinflammatory cytokine 
production including Tumor Necrosis Factor – α (TNF-α) and Interleukin-6 (IL-6) in isolated 
whole-brain tissue compared to low-fat control mice [25].   
Proposed Mechanisms Involved in AD Development 
Several proposed mechanisms involved in progression of the neurodegenerative state 
have been postulated.  Among these, two predominant mechanisms have been proposed that 
could generate symptoms of AD.  The first mechanism is the formation of Aβ plaques, a 
process sometimes referred to as abnormal protein aggregation.  Aβ is derived from amyloid 
precursor protein (APP), which was mentioned earlier as one of the genes in which rare 
mutations can lead to early-onset AD.  Production and aggregation of Aβ peptides is believed 
to be associated with synaptic dysfunction and neuronal death.  Aggregation of the Aβ 
peptides and neurofibrillary tangles begins before the onset of mild cognitive impairment 
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(MCI) and are associated with generation of ROS, resulting in membrane lipid peroxidation 
and neuronal death.  Aβ accumulation is a hallmark pathological and diagnostic indicator of 
AD [26-28]. 
A second proposed mechanism suggests that increased neuroinflammation through 
activation of resident immune cells results in increased neuronal loss, and subsequent 
neurodegeneration.  Neuroinflammation in different regions of the brain results from the 
generation of several types of molecules, including pro-inflammatory cytokines, chemokines, 
and immunoregulators.  An exaggerated immune response is considered the predominant 
source of these inflammatory molecules.  In many cases, neuroinflammation is used to fight 
off infection and in maintaining proper brain function through apoptosis of damaged neurons 
[29].   
The central nervous system (CNS) is tightly regulated in terms of the immune 
response.  For many years, the CNS has been considered an “immune-privileged” organ 
under strict control by the blood brain barrier (BBB).  However, the immune response of the 
brain may be more dynamic than once believed with new discoveries regarding microglial 
function, the brain’s innate immune cells, and recent reports that certain agents, including 
WD-feeding, can alter BBB permeability [29,30].   
Role of Microglia in Neuroinflammation 
 Microglia are cells within the brain that can be derived from myeloid cells, 
particularly monocytes, from the peripheral circulation.  They comprise 12% of the cells 
within the brain, with the highest concentrations of microglia present in the hippocampus and 
substantia nigra.  Microglia provide structural support and can act as immunocompetant cells 
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within the CNS.  Each microglial cell has been hypothesized to function as a hybrid between 
a white blood cell and a glial cell [29] .   
Microglial function is similar to that of macrophage.  Microglia express MHC class II 
molecules and they have the capacity for antigen presentation (AP) to other immune cells for 
recognition and destruction.  Microglia also secrete proinflammatory molecules, i.e.  
cytokines and chemokines, upon activation.  Microglial function helps to clear infectious 
agents within the CNS as well as facilitate apoptosis of damaged cells.  Stimulated microglial 
cells enable neurons to recover from traumatic stress and injury and have been reported to 
facilitate guided migration of stem cells to sites of inflammation and injury.  Microglia also 
express TLRs 1-9 on their cell surface and intracellularly, which enables them to respond 
efficiently to different types of pathogens as part of the innate immune system [31]. 
Innate Immune Response and Toll-Like Receptor Signaling 
 The body’s response to infection from microbial pathogens relies on both the innate 
and adaptive immune responses.  The innate immune response acts immediately after an 
infectious challenge; and its actions are conducted largely by modified monocytes, especially 
macrophage.  Macrophages can phagocytose and kill pathogens, as well as produce several 
inflammatory mediators and cytokines [32] .  The ability of these innate immune cells to 
recognize foreign pathogens and initiate the immune response relies heavily on surface and 
intracellular receptors that have adapted through time to respond to a wide variety of foreign 
molecules.  Among the pattern-recognition receptors (PRRs), Toll-like receptors (TLRs) 
have been identified as respondents to a large variety of bacterial, viral, and fungal agents 
and represent one of the first lines of defenses against invading pathogens [33] . 
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 Mammalian TLRs are highly conserved receptors which share sequence similarity 
with Toll proteins, essential molecules in embryonic patterning and antifungal protection 
found in drosophila [34,35].  Mammalian TLRs are type 1 transmembrane protein receptors 
found on a variety of innate immune cells including macrophages, neutrophils, natural killer 
cells, and microglia.  As part of the innate immune system, TLRs are capable of 
differentiating between self and foreign pathogens [34] .  In addition, TLRs are also related 
to the IL-1 receptor; however, the extracellular, leucine-rich repeat domains of TLRs are very 
different from the extracellular domain of IL-1R.  TLRs respond to specific molecular motifs 
called pathogen associated molecular patterns (PAMPs) found on a variety of pathogens in 
microbial, viral, and fungal organisms [34,36].  As of 2012, 10 human TLRs and 12 mouse 
TLRs have been discovered and are known to respond to specific ligands, both physiological 
and synthetic [37].  Microglial TLRs are present either on the plasma membrane (TLR-
1:TLR-2, TLR-2, TLR-2:TLR-6, TLR-4, TLR-4:TLR-6, TLR-5, and TLR-11(mouse)) or on 
the endosomal membrane (TLR-3, TLR-7, TLR-8, and TLR-9).  Although some ligands for 
certain TLRs have yet to be characterized, a list of known TLRs and respective ligands are 
characterized in Table 1. 
The first identified and most potent TLR ligand is lipopolysaccharide (LPS), a 
component of the cell wall of Gram negative bacteria.  LPS, also known as endotoxin, which 
is normally bound to a soluble factor called LPS binding protein (LBP) associates with a 
phosphatidylinositol-anchored cell surface molecule of microglia called cluster of 
differentiation 14 (CD14), which in turn activates TLR-4 signaling.  In addition, a small 
secreted molecule called MD-2 associates with TLR-4 and is essential for LPS recognition 
through TLR-4 homodimerization.  TLR-4 activation leads to several different downstream 
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events that ultimately regulate the innate immune response and inflammation.  Of particular 
interest is the activation of Nuclear Factor Kappa-light-chain-enhancer of activated of B-cells 
(NF-ᴋB), a proinflammatory transcription factor which enhances cytokine and inflammatory 
mediator production [33,34].  Downstream events of TLR-4 activation can lead to several 
different outcomes dependent on localization of several intermediate steps.  Initially, it was 
thought that myeloid differentiation primary response protein 88 (MyD88) was a necessary 
signaling adaptor for effective TLR-4 signaling; however, MyD88 deficient mice still 
promote changes that protect them against viral infections through upregulation of IRF-3 
upon TLR-4 stimulation and signaling through another adaptor molecule called TIR-
containing adaptor inducing interferon-β (TRIF) [33,34] .  The TLR-4 signaling pathway is 
represented in Figure 1. 
Lipopolysaccharides and Saturated Fatty Acids 
 Initially, LPS was thought to be the only ligand for TLR-4 stimulation. LPS is 
highly conserved across species and contains a core of hydrophilic polysaccharides, an O 
antigen, and a hydrophobic lipid A tail.  The lipid A tail is considered the main inducer of the 
biological responses of LPS [38].  Lipid A of E. Coli and S. 11typhimurium is a β-1,6 linked 
disaccharide of glucosamine acylated with R-3-hydroxylaurate or myristate and 
phosphorylated at positions 1’ and 4’.  The 3-hydroxyl groups of these saturated fatty acids 
are further 3-O-acylated by lauric acid, myristic acid, or palmitic acid.  When the lipid A tail 
is deacylated, capable through the enzyme, acyloxyacyl hydrolase, it loses its endotoxic 
properties and acts antagonistic to TLR-4 signaling [39].  This finding, originally reported in 
a 1986 study, suggests saturated fatty acyl moieties of the lipid A tail may be essential to 
initiate proinflammatory signaling through the TLR-4 complex [40].  In more recent
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Table 1.  Microglial Toll-like Receptors, Cellular localization, and Associated Ligands 
Toll-like 
Receptors 
Cellular 
Location 
Physiological Ligands Synthetic ligands 
TLR-1:TLR-2 Plasma Membrane Triacylated lipopeptides Pam3CSK4 
TLR-2 Plasma Membrane Peptidoglycan, phospholipomannan, tGPI-mucins, 
haemagglutinin, porins, lipoarabinomannan, 
glucoronoxylomannan, high-mobility group box 1 
protein (HMGB1) 
Not determined 
TLR-2: TLR-6 Plasma membrane Diacylated lipopeptides, lipoteichoic acid, zymosan S-(2,3-bispalmitoyloxypropyl)-CGDPKHSPKSF, 
macrophage-activating lipopeptide of 2kDa, Pam2CSK4 
TLR-3 Endosomal 
Membrane 
Double-stranded RNA Polyl:C 
TLR-4 Plasma Membrane Gram negative bacterial lipopolysaccharide, 
vesicular stomatitis virus glycoprotein, mouse 
mammary tumour virus envelope protein, mannans, 
glycosylinositol phospholipids, Viral envelope 
proteins, heat shock proteins, fibrinogen, nickel, 
HMGB1 
Not determined 
TLR-4: TLR-6 Plasma membrane Oxidized low-density lipoprotein, amyloid-β fibrils Not determined 
TLR-5  Plasma Membrane Flagellin Not determined 
TLR-7 Endosomal 
Membrane 
Single-stranded RNA Imiquimod, resiquimod, loxoribine 
TLR-8 Endosomal 
Membrane 
Single stranded RNA Resiquimod 
TLR-9 Endosomal 
Membrane 
DNA, haemozoin CpG-A, CpG-B, and CpG-C oligodeoxynucleotides 
TLR-11 Plasma  
membrane 
Profilin Not determined 
 
Adapted from  (Lee, Avalos and Ploegh 168-179)
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Figure 1.  TLR-4 signaling pathway upon LPS stimulation (Adapted from PharmaProjects 
and ClipArt) 
 
  
research, greater focus has been placed on the role of dietary saturated fatty acids (SFAs) and 
TLR-4 signaling as a means for promoting long-term, low-grade inflammation. 
Saturated Fatty Acids and Inflammation: a Role for TLR-4 
Several studies have investigated high-fat diet induced inflammation in many areas of 
the body implicating it in the etiology of several diseases related to MetS. High-fat diet 
induced inflammation has been mainly studied in 3T3-L1 adipocytes and peritoneal 
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macrophages.  Both adipose tissue and macrophages have been reported to produce 
significant quantities of inflammatory molecules, which are increased in diets high in 
saturated fats.  Ajuwon et al. (2005) investigated the effect of culturing 3T3-L1 adipocytes 
with palmitate (SFA) on expression of several inflammatory cytokines and mediators.  They 
reported a 3.5-fold increase in NFᴋB activity as measured through a luciferase enzyme assay, 
as well as inducing increases in IL-6 mRNA and protein expression.  Results from this 
experiment indicate that palmitate is capable of inducing inflammation in adipocytes; 
however, a specific mechanism linking palmitate and NFᴋB activation was not investigated.  
High-fat diet-induced insulin resistance is thought to be mediated in part through changes in 
inflammation in adipose tissue and adipocytes, and TLR-4 mutation has been reported to 
attenuate HFD-induced insulin resistance [43,47,48].  Therefore, to better understand the 
underlying mechanism, several studies have focused on the role of TLR-4 in HFD-induced 
changes in the adipocyte inflammatory state [41,42]. 
  Shi and colleagues (2006) linked TLR-4 to inflammatory changes in adipose tissue 
and adipocytes stemming from either high saturated fat diets or the presence of palmitate.  
Before investigating the potential role of TLR-4 in adipocytes, the authors wanted to confirm 
a link between palmitate and TLR-4 signaling.  The authors used a 293T cell transfection 
experiment to confirm that palmitate works through TLR-4 in a MyD88-dependent process to 
induce NFᴋB activation.  Shi and co-researchers then addressed palmitate induced 
inflammatory changes through TLR-4 in 3T3-L1 adipocytes.  Shi and co-researchers (2006) 
confirmed that TLR-4 mRNA is significantly expressed in 3T3-L1 adipocytes, isolated 
mouse adipocytes, and adipose tissue, and confirmed that TLR-4 is functional through LPS 
stimulation in the 3T3-L1 adipocytes.  Shi et al. (2006) reported that 3T3-L1 adipocytes 
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stimulated with free fatty acids (FFA) had increased cytokine production (TNF-α and IL-6); 
however 3T3-L1 adipocytes with a TLR-4 knockdown through TLR-4 siRNA did not show 
any change.  In addition, adipocytes were harvested from WT and TLR-4 
-/-
 mice and 
stimulated with both LPS and FFAs.  In WT adipocytes, LPS, and to a lesser extent FFAs, 
induced both IL-6 and TNF-α production; however this induction was absent in the TLR-4 -/- 
adipocytes [43].   
As part of the in vivo portion of the study, Shi et al. (2006) fed WT and TLR-4 
-/-
 
mice either a high-fat diet (HFD) or low-fat diet (LFD), and harvested adipose tissue.  The 
authors reported that even though both mouse types gained significantly more weight on the 
HFD, the TLR-4 
-/-
 mice were more insulin sensitive.  In addition, WT mice exhibited 
increased HFD-induced adipose tissue expression of IL-6, MCP-1, SOCS3, TNF-α, as well 
as the macrophage marker F4/80.  Though adipocytes do express TLR-4 and produce 
inflammatory cytokines in vitro, previous studies have indicated that adipose tissue from 
obese individuals exhibit higher levels of macrophage infiltration, which could be 
contributing to increased inflammatory molecules being produced by the tissue [43,44]. 
Suganami et al. (2006) investigated the interaction between co-cultured adipocytes 
and macrophage, in order to better understand a mechanism linking saturated fats to reported 
increases in inflammation produced in adipose tissue.  These researchers examined the 
relative contribution to inflammatory changes of adipocytes and macrophage in co-culture.    
The investigators used a magnetic cell sorting to completely separate the adipocytes and 
macrophage, as confirmed through exclusively expressed markers: adiponectin (adipocytes) 
and F4/80 (macrophage).  They assessed relative mRNA levels for several markers in the two 
cell fractions and found that mRNA of macrophage chemotactic protein-1(MCP-1) was 
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significantly up-regulated in both macrophage and adipocytes, though at much higher 
concentrations in adipocytes [44].   
In contrast to previous reports, TNF-α mRNA was only up-regulated in the 
macrophage fraction, indicating that the majority of inflammatory changes that result from 
circulating FAs (produced by lipolysis in adipocytes) directly stem from macrophages 
present in adipose tissue, rather than from adipocytes themselves.  In addition, Suganami’s 
research team examined the role of TNF-α released by macrophage and the role of palmitate, 
the most abundant FA released by adipocytes, as a potential paracrine mediator of 
inflammation.  They found that TNF-α was capable of inducing NFᴋB activation in 
adipocytes and that palmitate was capable of inducing TNF-α production through a NFᴋB-
dependent process in RAW264.7 macrophages, a standard macrophage culture cell model 
[44].   
Suganami et al. (2007) harvested macrophages from C3H/HeJ and C3H/HeN mice to 
assess the role of TLR-4 in this process.  C3H/HeJ mice possess a natural loss of function 
mutation in TLR-4, whereas C3H/HeN mice are their respective TLR-4 intact controls.  
Suganami and co-workers (2007) also reported that both LPS (positive control) and palmitate 
induced TNF-α in macrophages isolated from the C3H/HeN mice.  In contrast, this increase 
in TNF-α expression was greatly attenuated in the macrophages isolated from TLR-4 mutant 
C3H/HeJ mice.  Suganami and co-researchers (2007) also investigated levels of lipolysis by 
adipocytes in the presence of macrophage from either C3H/HeJ or C3H/HeN mice.  FA 
release was significantly decreased in the adipocyte co-cultured with C3H/HeJ macrophage 
as compared to co-cultures of adipocytes with C3H/HeN macrophage, indicating a role of 
TLR-4 in regulating both inflammation and lipolysis in adipose tissue [45].   
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Many reports have demonstrated the role of TLR-4 in regulating inflammation in 
individuals with HFD-induced obesity, as well as playing a role in several disorders 
associated with MetS.  A study by Tsukomo et al. (2007) investigated the role of TLR-4 as a 
candidate between metabolic signals, inflammation, and insulin resistance.  The investigators 
gave C3H/HeJ and C3H/HeN mice either a chow control diet or a HFD (55% from fat) 
experimental diet.  Tsukomo et al. (2007) reported that the C3H/HeJ mice were protected 
against diet-induced obesity, as well as exhibiting decreased adiposity, increased oxygen 
consumption, decreased respiratory exchange ratio, greater insulin sensitivity, and increased 
insulin signaling capacity in adipose tissue, muscle, and liver.  Furthermore, TLR-4 mutation 
in the C3H/HeJ mice prevented IᴋB kinase and c-Jun NH2-terminal kinase activity, which are 
both involved in NFᴋB activation and production of inflammatory molecules.  Taken 
together, results indicated a critical role of TLR-4 in the development of HFD-induced 
insulin resistance, potentially mediated through increased inflammation [42,45].  Considering 
the relationship between MetS-associated disorders, such as insulin resistance, with AD 
development, TLR-4 could be playing a role in regulating HFD-induced neuroinflammation, 
which may lead to increased AD risk. 
TLR-4, HFD, and Neuroinflammation 
Few studies have addressed the role of TLR-4 in HFD-induced changes in 
neuroinflammation.  Considering the similarity between macrophage and microglial function 
and that both cell types express TLR-4, as well as many other TLRs, it’s likely that many of 
the same processes exist.  In addition, dietary fats are transported into the brain through a 
process still under investigation, but reported to involve both active transport through 
FATP1, FAT/CD36 and passive diffusion [46].  
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A Milanski et al. (2009) study presented evidence that TLR-4 signaling is upregulated 
and activated by long chain saturated fatty acids and this contributes to increased ER stress in 
the brain (hypothalamus) of TLR-4 intact C3H/HeN mice, but not C3H/HeJ mice [47].  This 
study followed up a report by Tsukomo et al. (2007) hypothesizing that dietary fats act 
through TLRs 2/4 and endoplasmic reticulum stress to induce cytokine expression in the 
hypothalamus, leading to functional resistance to the anorexigenic hormones, insulin and 
leptin [42].  Milanski et al. (2009) used both Wistar rats and the C3H/HeJ and C3H/HeN 
mice fed either a chow or one of two high fat (36.0 g% fat from lard or 36.0g% oleic acid 
rich) diets.  The results of their study indicated that long chain saturated fatty acids act 
through TLR-4 to promote increased inflammatory protein expression in the hypothalamus, 
increased cytokine production, increased ER stress, and TLR- 2/MyD88 and TLR-4/MyD88 
upregulation in rats.  In addition, loss or inhibition of TLR-4 protected against diet-induced 
body mass gain, impaired leptin resistance, and arachidic acid-induced hypothalamic 
cytokine expression.  The Milanski (2009) study clearly indicated that TLR-4 plays a major 
role in regulating inflammation in the hypothalamus, as well as contributing to disorders 
related to obesity and MetS [42,47]. 
Milanski et al. (2009) reported that both TLR-2 and TLR-4 were upregulated and 
constitutively activated in the hypothalamus, and that TLR-2 and TLR-4 were exclusively 
expressed on microglia within the hypothalamus following a high fat diet.  In addition to 
increased or constitutive activation of TLRs caused by high saturated fats, the microglia will 
also respond more vigorously to agonists such as LPS or peptidoglycans, and produce 
increased levels of proinflammatory molecules [47].  This phenomenon is known as 
“microglial priming.”  Many events can occur which result in more reactive immune cells 
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such as “primed microglia.”  In addition, another study with similar dietary conditions to the 
Milanski study (2009) indicated that 8 weeks of high-fat feeding was sufficient to increase 
apoptotic markers in the hypothalamus, microglial activation through increased F4/80 
expression, and TLR-4 upregulation.  In addition, this study reported that loss of TLR-4 
activity in C3H/HeJ mice, compared to C3H/HeN control mice, prevented body mass gain 
with equivalent dietary food intake and altered expression of apoptotic markers [48]. 
Preliminary data from the Sheridan lab (unpublished data) reported that early 
infection with herpes simplex virus 1 (HSV-1), primed microglia isolated from C57BL/6 
whole brain display increased pro-inflammatory gene expression including TLR-4.  
Microglia harvested from HFD, HSV-infected mice had higher expression levels of several 
markers of priming and inflammatory cytokines including TLR-4, MHCII, CD80, CD86, 
CD11b, IL-1β, and TNF-α compared to LFD, HSV-infected mice, implicating a role of HFD 
in contributing to increased TLR-4 surface receptor expression. 
Hypotheses 
Previous research has focused on either the role that TLR-4 plays in other areas of the 
body than the brain, or how HFD can contribute to increased neuroinflammation in areas of 
the brain less related to Alzheimer’s development.  We examined the effect of HFD on 
neuroinflammation within the hippocampus, an important site in AD development.  
Furthermore, investigation of the role that TLR-4 plays in mediating HFD-induced 
neuroinflammation was warranted, since previous reports have indicated a role of TLR-4 in 
mediating HFD-induced inflammation in other tissues.  Our primary hypothesis was that 
mice fed a high-fat diet (HFD) for 8 weeks will exhibit increased levels of 
neuroinflammation within the hippocampal region compared to low-fat fed controls.  In 
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addition, we postulated that 8 weeks of HFD-feeding will result in increased surface 
expression of TLR-2 and TLR-4.  Our secondary hypothesis was that loss of TLR-4 activity 
would prevent HFD-induced increases in neuroinflammation. 
In order to investigate the effect of HFD-feeding on neuroinflammation in the 
hippocampus, C57BL/6 mice were fed either a high fat diet (HFD) consisting of 45% 
calories from lard/soybean oil, or a low-fat control diet (LFD) consisting of 10% calories 
from the same fat source.  This LFD control diet was more reflective of a true low-fat control 
diet, as previous studies, including the Milanski (2009) and Moraes (2009) studies, utilized 
normal chow diets with highly variable fat sources.  After assessing status of 
neuroinflammatory mediators and changes in microglial surface receptor expression in the 
C57BL/6 mice, the role of TLR-4 in mediating HFD-induced neuroinflammation was 
examined by using C3H/HeJ mice, which as mentioned previously, have a natural loss-of-
function mutation in TLR-4.  C3H/HeJ mice and C3H/HeN mice, and their respective TLR-4 
intact controls, were fed the same HFD and LFD for 8 weeks.  We measured cytokine 
transcriptional changes and microglial reactivity.   
The results of these two experiments are presented in Chapter 2.
  
 
Chapter II – Journal Manuscript1 
INTRODUCTION 
Neurodegenerative disease such as Alzheimer’s disease represents a growing public 
health concern with prevalence increasing both domestically and world-wide.  
Neurodegenerative disease is characterized by loss of structure and function of neurons 
within various regions of the brain, leading to symptoms such as cognitive 
impairment/dementia.  Age has long been considered the most predominant risk factor for 
Alzheimer’s development.  Considering shifts in the age distribution of the US population 
towards older aged individuals, the population at risk for this disease continues to increase.  
This has placed greater economic burden on the health community, emphasizing the 
importance of research in this field towards developing new screening techniques, better 
treatment options, as well as discovering preventative measures.  Unlike other diseases such 
as cancer, diabetes, or cardiovascular disease, treatment for neurodegenerative disease 
remains scarce as many of the risk factors are either unknown or insufficiently characterized 
[1] .  Determining risk factors for diseases with long developmental periods such as 
Alzheimer’s disease can be a difficult task.  In recent years, several potential risk factors for 
neurodegenerative disease development have been proposed and investigated. 
Alzheimer’s is considered a multi-factorial disease with both genetic and 
environmental influences.  Early onset AD is characterized by rare mutations in the APP 
gene, as well as mutations in PS-1 and PS-2; however, these represent only a small 
percentage of the population who develop AD.  A more common gene polymorphism, 
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APOEε4, has been associated with increased AD development, representing a main genetic 
influence for late-onset AD.  This polymorphism is not sufficient to cause AD development 
on its own [7].  In general, environmental factors likely play a larger role in AD etiology over 
the course of a patient’s lifetime. 
Disorders associated with Metabolic Syndrome (MetS) have been given greater focus 
within this research field as potential risk factors.  Insulin resistance, Type II Diabetes, 
Vascular Disease, Atherosclerosis, and Obesity have all been associated with increased risk 
of AD development.  Obesity contributes as a primary risk factor for all disorders related to 
MetS [8,12,13].    Recent longitudinal studies have associated obesity/BMI, as well as, 
increased dietary intake of saturated and trans-unsaturated fatty acids with increased AD risk 
[23,49,50,51].  Though it may be difficult to dissociate each MetS disorder and dietary intake 
in order to identify the true underlying mechanism, it is possible to address potential 
pathways that contribute to increased AD development. 
One proposed pathway that has been implicated in several MetS disorders is high fat 
diet-induced activation of innate immunity through Toll-like Receptor 4 (TLR-4).  
Polymorphisms in TLR-4 in the context of diet have been associated with several MetS 
disorders and age-related diseases, indicating that this may be a relevant target in AD disease 
pathology [47,52,53] TLR-4 is part of a family of Toll-like receptors that respond and 
activate the innate immune response upon binding to various pathogen associated molecular 
patterns (PAMPs) found on bacteria, viruses, and fungi.  Activation of the innate immune 
response increases levels of proinflammatory cytokines, chemokines, and immunoregulators.  
Classically, lipopolysaccharide (LPS), a main component in cell walls of gram-negative 
bacteria, is considered the ligand for TLR-4.  Binding of LPS to CD14, a TLR-4 co-receptor, 
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activates a downstream cascade of TLR-4, ultimately leading to increases in Nuclear Factor 
Kappa-light-chain-enhancer of activated B-cells (NF-ᴋB), a transcription factor that 
promotes production of pro-inflammatory cytokines and chemokines [34].  LPS contains 
three domains; an O antigen, a core polysaccharide, and a lipid A tail.  Evidence has shown 
that the lipid A tail, which contains multiple saturated fatty acyl moieties, is the endotoxic 
component of LPS [38].  When LPS is deacylated, it loses its endotoxic properties, indicating 
that saturated fats may be responsible for activating the inflammatory cascade associated 
with TLR-4 activation [40,54]. 
Microglia, the central nervous system’s primary innate immune cells, express TLRs 
1-9 and are capable of mediating inflammation in response to several different kinds of 
stimuli [29].  A primary proposed mechanism for the development of neuronal degradation, 
and subsequent neurodegenerative disease, is the over-activation of microglia in producing 
persistent, low-level inflammation within the brain.  Over-activation of microglia can be 
achieved through several different mechanisms.  Microglial priming is the hypothesis that 
certain stimuli either early on or consistently presented, causes the microglia to be more 
responsive and inflammatory when presented with future stimuli.  Another consideration is 
constitutive activation of TLR-4 through constant ligand recognition, as would be the case 
with components of an individual’s diet.  A 2009 article published by Milanski et al., 
demonstrated that high fat diet resulted in constitutively activated microglia in the 
hypothalamus, as well as increased ER stress [47].   
Several studies have addressed the role of saturated fatty acids (SFAs) in activating 
TLR-4 in the context of several diseases [33,36,38,39,41-45,47,48,54-57]; however, the role 
of TLR-4 in high-fat diet-induced neuroinflammation in the hippocampus has not been 
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thoroughly addressed.  We hypothesized that HFD would increase inflammation in the 
hippocampus after only 8 weeks of feeding, Further, loss of TLR-4 will protect against HFD-
induced neuroinflammation.  
METHODS AND MATERIALS 
Animals and animal care.  Weanling, male C3H/HeJ mice containing a naturally-occurring, 
loss-of-function TLR-4 mutation, their respective C3H/HeN control mice (NCI, Bethesda, 
MD); and C57BL/6J (Jackson Laboratories, Bar Harbor, ME) were housed at the University 
of North Carolina Animal Facility, which is fully accredited by the American Association for 
Accreditation of Laboratory Animal Care.  Animals were housed 4/cage under pathogen-free 
conditions and maintained under protocols approved by the Institutional Animal Care and 
Use Committee.  The mice were randomized to either a high-fat diet (HFD) consisting of a 
45% kcal by fat diet with soybean oil and lard as the fat source (D12451, Research Diets) or 
a 10% fat diet from the same fat source (D12450B).  Water and food were available ad 
libitum.  Body weights were measured at 6 and 12 weeks of age.  After 8 weeks, mice were 
killed by rapid cervical dislocation and the brain was removed, quickly dissected and flash 
frozen. 
Quantitative RT-PCR.  Total RNA was isolated using a commercially available acid-phenol 
reagent (TRIzol; Invitrogen, Carlsbad, CA).  Potential DNase contamination was removed 
with Amplification Grade Dnase 1 (Sigma Aldrich, St. Louis, MO).  RNA was re-extracted 
for purification using phenol: chloroform (5:1) in isoamyl alcohol, chloroform: isoamyl 
alcohol (24:1), and re-precipitated using Molecular Grade ethanol (200 proof) and 9M 
glycogen.  First-strand cDNA reverse transcription was synthesized using a master mix of M-
MLV Reverse Transcriptase 200 u/µL (Promega, Madison, WI) with 5X RT buffer 
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(Promega), Oligo (dT)15 primers, 10mM dNTP mix, and DEPC-treated water.   Thermal 
conditions were 42⁰C for 60 min followed by 95⁰C for 5 min, and held at 9⁰C until storage at 
-20⁰ C.  Quantitative Real-Time PCR (qRT-PCR) was carried out with previously described 
TaqMan Assays on Demand Primer Probe pairs (Applied Biosystems, Branchburg, NJ) to 
determine the mRNA expressions of GAPDH, IL-1β, IL-6, IL-10, TNF-α, MIF, SOCS-3 in 
each tissue fraction for all three mouse strains.  In addition, IFN-γ, MCP-1/CCL2, MIP-
1α/CCL3, and RANTES/CCL5 mRNA expression was determined for C3H/HeN and 
C3H/HeJ mice.  Real-time reactions were carried out on a CFX96 Real-Time System 
(BioRad, Hercules, CA) with BioRad CFX Manager using TaqMan Universal PCR Master 
Mix (Applied Biosystems).  All genes of interest were normalized to GAPDH mRNA 
expression.  
Microglial Isolation.  Microglia were isolated following a previously published method (17).  
Briefly, whole brains were removed and homogenized in HBSS.  Single cells suspensions 
were filtered through 70 μM nylon mesh and centrifuged at 500Xg for 5 min.  The cells were 
re-suspended in 70% Isotonic Percoll (Sigma) and then layered with 50%, 35% and 0% 
isotonic Percoll.  The Percoll gradient was centrifuged at 2000Xg for 20min at room 
temperature.  The microglia layers were located at the 70/50% interphase and were carefully 
collected, washed 2 times with HBSS, and finally re-suspended in complete RPMI.   
Microglial TNF-α and IL-6 ELISA Immunoassay.  Isolated microglia were plated with 1 X 
10
5
 cells per well on a 96-well plate.  Microglia were incubated with either media, 
Pam2CSK4 (a synthetic TLR2 ligand), or purified LPS for 16 hours.  Supernatants were 
collected for quantifying TNF-α and IL-6 protein expression through ELISA assays (R & D 
systems).   
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Splenocyte TNF-α and IL-6 ELISA Immunoassay.  Splenocytes were isolated in 
unsupplemented HBSS.  Samples were processed into single-cell suspensions by mechanical 
agitation of a Stomacher (Seward) and strained througha 40-µM nylon filter.  Cells were 
subjected to RBC lysis using ACK lysis buffer for 6 min at room temperature, washed, and 
counted.  Isolated splenocytes were plated 1 X 10
6 
cells per well on a 96-well plate.  
Splenocytes were incubated with either media, Pam2SCK4, or purified LPS for 48 hours.  
Supernatants were collected for qualifying TNF-α and IL-6 protein expression through 
ELISA assays (R & D systems). 
Flow Cytometry.  Previously plated microglia were washed and re-suspended in DMEM, 5% 
FBS, and incubated with anti-CD16/32 to block non-specific binding to Fc receptors.  
Microglia were then surface-stained with anti-CD11b, CD45, TLR-2, and TLR-4 antibodies 
for flow cytometric analysis to determine the Mean Fluorescence Intensity (MFI).  Cells are 
analyzed using an Accuri Flow Cytometer (Accuri, Ann Arbor, MI) and data analysis is 
performed using Flow Jo software (Tree Star, Ashland, OR). 
Serum Leptin and Resistin ELISA Immunoassay.  To determine markers of obesity status 
and leptin resistance, serum leptin and serum resistin were measured by ELISA (R & D 
systems) in serum collected from fed mice. 
Statistical Analysis.  Weight data for C57BL/6 mice were analyzed using a Student’s T test.  
Percent weight gain data and qRT-PCR data were analyzed using the Kruskall-Wallis test.  
Serum ELISA data were analyzed using 2 way ANOVA with post hoc Students’ T test.  
Microglial TNF-α and IL-6 ELISA data were analyzed using 3 way ANOVA with post hoc 
Tukey’s HSD.  Flow Cytometry data was analyzed using Flow Jo Analysis software.  
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Microglial TLR-2 and TLR-4 MFI data were analyzed using a Student’s T test, comparing 
treatment to media control.  All statistical analyses were performed using JMP Statistical 
Software (SAS Institute).  Values are the mean ± SEM.  Data were considered statistically 
significant if P < 0.05. 
RESULTS 
C57BL/6 mice gain significantly more weight on the high fat diet after 8 weeks.  After 8 
weeks of high fat feeding, C57BL/6 mice gained significantly more weight (p = 0.0002) than 
low-fat fed C57BL/6 mice (Figure 2). 
C57BL/6 mice have increased neuroinflammation in the hippocampus following a high-fat 
diet.   In order to assess potential changes in neuroinflammation as an effect of HFD, qRT-
PCR was performed on RNA extracted from hippocampi of C57BL/6 mice fed either a LFD 
or a HFD.  TNF-α mRNA was significantly increased in the hippocampus of HFD-fed mice 
(p = 0.03) as compared to LFD-fed mice (Figure 3A).  In addition, IL-10 was significantly 
decreased (p = 0.006) in the hippocampus of the HFD-fed mice (Figure 3B).  There were no 
significant differences in hippocampal mRNA levels of IL-1β, IL-6, MIF, or SOCS-3 
comparing LFD-fed and HFD-fed mice (data not shown). 
HFD increased TLR-2 and TLR-4 on microglia harvested from C57BL/6 whole brain 
tissue.  HFD significantly increased the expression of TLR-2 and TLR-4 on microglia 
isolated from whole brains compared to LFD-fed mice (Figure 4).  
C3H/HeJ mice gained significantly more weight than C3H/HeN mice following a high-fat 
diet, corresponding to differences in serum leptin.  In order to investigate the potential role 
of TLR-4 in mediating the observed increases in neuroinflammation in the hippocampus, we 
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utilized C3H/HeJ mice, which have a natural loss-of-function mutation in TLR-4, compared 
to C3H/HeN mice, their respective TLR-4 wild-type controls.  After 8 weeks on the high fat 
diet, both C3H/HeN mice and C3H/HeJ mice gained significantly more weight (p ≤ 0.0001) 
(Figure 5A).  In addition, HFD-fed C3H/HeJ mice gained significantly more weight (20.8 ± 
0.7%) compared to HFD-fed C3H/HeN mice (12.4 ± 0.8%) in respect to LFD-fed controls (p 
≤ 0.0001) (Figure 5B).  Leptin was significantly increased in the serum of HFD-fed C3H/HeJ 
mice, but not in the HFD-fed C3H/HeN serum samples (Figure 5C).  The leptin data 
corresponds to the weight gain data presented in Fig. 5B.  Leptin was also increased in the 
C3H/HeN mice; however this increase was not significant.  
HFD decreased IL-6 mRNA levels in hippocampi of C3H/HeN mice, but not C3H/HeJ 
mice.  IL-6 mRNA was decreased (p = 0.05) in hippocampi isolated from HFD-fed 
C3H/HeN compared to LFD-fed controls (Figure 6A); however, this dietary effect was not 
seen in C3H/HeJ mice.  Furthermore, there were no changes as an effect of diet in any of the 
pro-inflammatory cytokines tested, including TNF-α (Fig. 6B), IL-1β (Fig. 6C), IL-10, MCP-
1, MIP-1α, or RANTES (data not shown). 
HFD decreases MIF mRNA in the hippocampus of C3H/HeN mice, but not C3H/HeJ 
mice.  MIF transcription was significantly decreased (p ≤ 0.01) in the hippocampus (Figure 
7) of HFD-fed CH3/HeN mice compared to LFD-fed controls; however, there was no 
difference between HFD-fed C3H/HeJ and LFD-fed C3H/HeJ mice.   
HFD decreases SOCS-3 mRNA expression in the hippocampus of C3H/HeN mice, but not 
C3H/HeJ mice.  SOCS-3 transcription is decreased (p = 0.0562) in the hippocampus of 
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HFD-fed C3H/HeN mice, but not in HFD-fed C3H/HeJ mice (Figure 8), indicating a 
potential role of TLR-4.   
TLR-2 and TLR-4 receptor expression is upregulated following stimulation with LPS in 
microglia isolated from HFD-fed C3H/HeN mice in a TLR-4 dependent manner.  TLR-2 
and TLR-4 surface receptor expression was significantly upregulated (α = 0.05) following 
stimulation with purified LPS in microglia isolated from HFD-fed C3H/HeN mice compared 
to media controls (Fig. 9A and Fig. 9B).  There were no significant differences between LPS 
and media stimulation in microglia isolated from LFD-fed C3H/HeN mice, LFD-fed 
C3H/HeJ mice, or HFD-fed C3H/HeJ mice.  Pam2CSK4, a synthetic TLR-2 ligand, did not 
increase TLR-2 or TLR-4 receptor expression in any samples compared to media controls 
(Fig. 8C and Fig. 8D). 
TNF-alpha production was significantly decreased in microglia isolated from HFD-fed 
C3H/HeN mice following LPS and Pam2CSK4 stimulation compared to LFD-fed 
C3H/HeN microglia.  LPS stimulation increased TNF-α expression in microglia isolated 
from both LFD-fed and HFD-fed C3H/HeN mice compared to media stimulated microglial 
controls.  As expected, LPS did not increase TNF-α in microglia isolated from C3H/HeJ 
mice.  In C3H/HeN microglia, TNF-α expression was decreased in HFD-fed microglia 
compared LFD-fed microglia following LPS stimulation (Fig. 10A).  Pam2CSK4 increased 
TNF-α expression in microglia isolated from both LFD-fed and HFD fed C3H/HeN mice; 
however, there were no significant differences between Pam2CSK4 and media stimulation in 
microglia isolated from C3H/HeJ mice.  TNF-α expression decreased in microglia isolated 
from HFD-fed C3H/HeN mice compared to LFD-fed C3H/HeN mice following Pam2CSK4 
stimulation (Fig. 10B).   
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IL-6 production in microglia isolated from C3H/HeN and C3H/HeJ mice fed either a low-
fat diet or a high-fat diet.  LPS significantly increased IL-6 in microglia isolated from LFD-
fed C3H/HeN mice compared to media controls.  As expected, LPS did not induce IL-6 
production from microglia isolated from C3H/HeJ mice.  There were no differences in IL-6 
expression between LFD and HFD in either C3H/HeN or C3H/HeJ mice following LPS 
stimulation (Fig. 10C).  Pam2CSK4 significantly increased IL-6 protein expression in both 
LFD and HFD-fed C3H/HeN microglia but only LFD-fed C3H/HeJ microglia.  There was no 
significant difference in IL-6 in microglia isolated from HFD-fed C3H/HeJ.  There were no 
differences in IL-6 expression between LFD and HFD in either C3H/HeN or C3H/HeJ mice 
following Pam2CSK4 stimulation (Fig. 10D). 
Effect of HFD-feeding on inflammatory response in isolated splenocytes.  TNF-α 
production was significantly increased following LPS stimulation in splenocytes from both 
LFD-fed and HFD-fed C3H/HeJ mice as compared to media controls.  As expected, LPS did 
not induce TNF-α production in splenocytes isolated from C3H/HeJ mice.  (Fig. 11A).  
Pam2CSK4 stimulation significantly increased TNF-α production in all four treatment 
groups as compared to media controls; however, HFD did not augment this response (Fig. 
11B).  LPS stimulation resulted in significantly higher production of IL-6 in HFD-fed 
C3H/HeN mice only, indicating a role of TLR-4 in HFD-induced increases in IL-6 
production (Fig. 11C).  Stimulation with Pam2CSK4 increased IL-6 production only in 
C3H/HeN mice only, and there was no effect of HFD-feeding (Fig. 11D). 
DISCUSSION 
While many studies of the effect of HFD on the brain have focused on the 
hypothalamus [47,48,58], fewer have focused on the effects on the hippocampus.  However, 
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there is a growing body of literature, in both rodents and humans, that points to a role for 
obesity and/or the consumption of a diet high in saturated fat on increased 
neuroinflammation, memory impairment, and dementia including Alzheimer’s disease 
[1,8,9,15,18,19,21-23,25,30,49-51,59-72]. Excessive neuroinflammation caused by 
prolonged microglial activation has been hypothesized to play a major role in many 
neurological disorders and diseases including AD.  The goal of this study was to determine if 
relatively short-term feeding of HFD could increase inflammation in the hippocampus.  We 
found that after 8 weeks of HFD, C57BL/6 mice have increased inflammation in the 
hippocampus, as well as increased TLR-2 and TLR-4 receptor expression on isolated 
microglia.  Several studies have reported that saturated fatty acids (SFA) drive expression of 
inflammatory molecules through TLR-4 activation, specifically activation of the pro-
inflammatory transcription factor, Nuclear Factor Kappa-light-chain-enhancer of activated B-
cells (NF-κB) [9,42,44,47,54,73].  Both TNF-α and IL-10 transcription are controlled, in 
part, through TLR-4 signaling in microglia [47].  In our study, 8 weeks of HFD-feeding 
upregulated both TLR-2 and TLR-4/MD-2 surface expression on microglia isolated from 
whole brain from C57BL/6 mice.  Though our findings of elevated TLR-2 and TLR-4 in 
isolated microglia is not specific to the hippocampal region of the brain, it does indicate that 
microglia in the whole brain respond to HFD by upregulating inflammatory surface 
receptors.  The increase in TLR-2 and TLR-4 receptors on HFD microglia could account for 
the increase in TNF-α mRNA expression in the hippocampus. 
These findings are important as a very recent study has found that there may be a 
critical period for HFD exposure to result in learning and memory impairments [74].  In this 
study, only mice exposed to a HFD early in life showed deficits in learning and memory 
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tasks and altered neurogenesis in adulthood.  Hence, we hypothesize that the inflammation in 
the hippocampus early in life, as seen in our study, could contribute to the deficits in learning 
and memory. 
Previous studies have shown that in macrophage and hypothalamic microglia, SFAs 
are capable of signaling through TLR-4 to increase inflammation [39,44,47,54].  Therefore, 
we utilized the well-characterized C3H/HeJ model and the control C3H/HeN mice.  In 
contrast to C57BL/6 mice, HFD for 8 weeks did not increase pro-inflammatory gene 
expression, nor decrease anti-inflammatory gene expression in C3H/HeN mice.  In the 
C3H/HeN mice, which have intact TLR-4 signaling, we would have expected TNF-α 
transcription to increase in the hippocampus similar to C57BL/6 findings; however, we 
observed no significant changes at this time point.  In addition, transcription of IL-6, another 
pro-inflammatory cytokine, was significantly decreased in the TLR-4 intact mice, indicating 
a possible role of TLR-4 in decreasing IL-6. 
 While there was no increase in pro-inflammatory cytokines in the HFD-fed C3H/HeN 
mice, we observed a decrease in Macrophage Migration Inhibitory Factory (MIF) and 
Suppressor of Cytokine Signaling-3 (SOCS-3).  These decreases were abrogated in the 
C3H/HeJ mice, suggesting a role for TLR-4.  MIF plays a role in many pathways including 
the immune system as well as lipid and glucose metabolism [74-81].  MIF expression is 
typically increased in obesity, and can be induced by the presence of TNF-α, glucocorticoids, 
PPAR-γ, HBP-1 and resistin [76,77,83].  In this present study, a diet high in fat caused a 
significant decrease in MIF transcription in a TLR-4 dependent manner.  In addition, MIF 
transcription was significantly downregulated in a TLR-4 dependent manner after 8 weeks on 
the HFD in the liver of C3H/HeN mice (data not shown).  Several studies have shown a 
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strong association between TNF-α production and MIF transcription.  Though there were no 
differences in TNF-α mRNA expression, microglial activation assays reported a significant 
decrease in TNF-α production following stimulation with either a TLR-2 or TLR-4 agonist in 
the HFD-fed C3H/HeN microglia.  It is possible that the less inflammatory microglia in the 
HFD-fed, TLR-4 intact mice could be contributing to the observed differences in MIF 
mRNA levels through decreased TNF-α production. 
 SOCS-3 is upregulated in the presence of pro-inflammatory cytokines, as a means of 
negative feedback.  In addition, SOCS-3 has been implicated as one of the underlying 
mechanisms that leads to leptin and insulin resistance.  Brain-specific SOCS-3 deficiency in 
mice has been shown to increase leptin sensitivity through increased STAT3 tyrosine 
phosphorylation and confer protection from diet-induced obesity, insulin resistance, and 
hyperleptinemia [84].  Our study demonstrated that 8 weeks of HFD-feeding decreased 
SOCS-3 expression in the hippocampus in a TLR-4 dependent manner.  While leptin was 
increased in HFD-fed C3H/HeN mice, lower levels of SOCS-3 expression in HFD-fed, TLR-
4 intact hippocampus is the opposite of what we expected.  However, the high fat diet 
increased SOCS-3 expression in the C3H/HeJ mice in the liver (data not shown), which is 
expected considering a significant increase in serum leptin levels in these mice.  The data 
pertaining to hippocampal SOCS-3 expression could be specific to this region of the brain.  
Additional studies are needed to further elucidate these results. 
 In our study, the HFD exposure increased microglia surface expression of both TLR-
2 and TLR-4 following either LPS or Pam2CSK4 stimulation in a TLR-4 dependent manner.  
In C3H/HeN mice, despite upregulation in these inflammatory receptors, TNF-α production 
following either LPS or Pam2CSK4 stimulation was decreased in the microglia isolated from 
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HFD-fed C3H/HeN mice as compared to LFD-fed controls.  In contrast to the microglia, 
there was a significant increase in IL-6 production and no difference in TNF-α production in 
splenocytes isolated from HFD-fed C3H/HeN mice as compared to respective LFD-fed 
controls.  This may imply that 8 weeks of HFD-feeding was sufficient to increase the 
robustness of the inflammatory response in the periphery, but was not enough time to 
observe similar increases in the hippocampus. 
 While we were not able to determine if HFD-induced inflammation is induced by 
TLR-4 signaling, two recent studies have implicated that AMP-kinase and oxidative stress 
may be alternative mechanisms by which HFD increases inflammation.  In one study, 
C57BL/6 mice fed resveratrol along with a HFD for 20 weeks, had decreased hippocampal 
TNF-α and improved insulin and energy metabolism within the hippocampus.  Resveratrol-
treated mice also had improved memory function compared to HFD mice.  Importantly, 
resveratrol, while normalizing insulin and glucose levels, did not decrease weight, suggesting 
that obesity alone does not increase neuroinflammation [64].  Another study demonstrated 
that treatment of obese mice with ursolic acid, which has anti-inflammatory and antioxidant 
properties, improved the hippocampal-dependent learning and memory as measured by the 
Morris water maze task [85]. 
 High-fat diets have been recognized as a potential risk factor for AD development, 
and increased neuroinflammation is hypothesized to contribute to AD [8,15,21-23,30,49-
51,59,60,62,64,69,70,72,74,85-91].  We observed increased neuroinflammation in the 
hippocampus of C57BL/6 mice after 8 weeks of HFD-feeding.  The C3H mouse model may 
not be a good model for understanding the effect of high-fat diet on neuroinflammation in the 
hippocampus and subsequent AD development/cognitive impairment.  Future studies 
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utilizing TLR-4 knockout mice and treating with anti-oxidants or drugs that improve insulin 
sensitivity will further elucidate the underlying mechanism involved in HFD-induced 
hippocampal inflammation. 
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Figure 3.  TNF-α expression (A) and IL-10 expression (B) in hippocampus from C57BL/6 
mice fed 8 weeks of either LFD or HFD. Data are mean ± SEM, n = 8, 7.  *different from 
LFD, P < 0.05. 
Figure 2.  Mean weights of C57BL/6 mice fed for 8 weeks on either a low-fat or high-fat 
diet.  Data are mean ± SEM, n = 8, 7.  *different from LFD, P < 0.05.   
 
 
 
 37 
 
 
 
 
 
  
Figure 4.  Percent of microglial population expressing TLR-2 and TLR-4/MD-2 surface 
receptors isolated from whole brain of C57BL/6 mice fed 8 weeks of either LFD or HFD.  
Data are mean ± SEM, n = 8.  *different from LFD, P < 0.05.   
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Figure 5.  Mean Weights of C3H mice fed 8 weeks on either LFD or HFD (A), Percent 
Weight Gain after 8 weeks of HFD-feeding compared to LFD control (B), and Serum 
Leptin of C3H mice fed 8 weeks of either LFD or HFD (C).  Data are mean ± SEM, n = 8.  
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Figure 6.  IL-6 expression (A), TNF-α expression (B), and IL-1β expression (C) in 
hippocampus of C3H mice fed 8 weeks of either LFD or HFD.  Data are means ± SEM, n 
= 8.  *different from respective LFD control, P < 0.05. 
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Figure 7.  MIF expression in hippocampus from C3H/HeN and C3H/HeJ fed 8 weeks of 
either LFD or HFD.  Data are means ± SE, n = 8.  *different from respective LFD control, 
P < 0.05.  
  
Figure 8.  SOCS-3 expression in hippocampus of C3H/HeN and C3H/HeJ fed 8 weeks of 
either LFD or HFD.  Data are means ± SEM, n = 8.  P = 0.0562.   
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Figure 9.  TLR-2 (A, C) and TLR-4 (B, D) surface expression (Mean Fluorescence 
Intensity) on microglia isolated from whole brain of C3H mice fed 8 weeks of either LFD 
or HFD.  Data are means ± SEM, n = 6 (Media), 8 (LPS, Pam2CSK4).  *different from 
Media stimulation, P < 0.05. 
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Figure 10.  TNF-α and IL-6 production (pg/mL) in isolated microglia following LPS 
stimulation (A, C) or Pam2CSK4 stimulation (B, D).  Data are means ± SEM, n = 6 
(Media), 8 (LPS, Pam2CSK4).  Labeled means without a common letter differ, P < 0.05.  
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Figure 11. TNF-α and IL-6 production (pg/mL) in isolated splenocytes following LPS 
stimulation (A, C) and Pam2CSK4 stimulation (B, D).  Data are means ± SEM, n = 6 
(Media), 8 (LPS, Pam2CSK4).  Labeled means without a common letter differ, P < 0.05. 
 
 
 
 
 
 
 
  
 
Chapter III – Discussion 
Determining the causative mechanisms underlying the development of 
neurodegenerative disorders is a primary research focus in the AD community.  Previous 
investigations have identified several potential risk factors for AD including obesity, high-fat 
dietary patterns, cardiovascular disease, insulin resistance, type 2 diabetes, MetS, and genetic 
factors.  Most of these potential risk factors, like AD itself, are manifested over long time 
periods and may be modifiable through lifestyle changes.  The focus of this study is to 
investigate the effect of short-term HFD-feeding on neuroinflammation within the 
hippocampus.  This preventable dietary risk factor may be responsible for other reported risk 
factors for AD development.   
The results reported in Chapter 2 are presented in the context of current and previous 
investigations, and this chapter also includes discussion of the pertinent issues and research 
questions in this field of study.  Some of the difficulties in studying the effects of HFD-
feeding on parameters of neuroinflammation are in separating the effects of obesity per se 
from the acute effects of the dietary fat components, as well as determining the optimal 
duration of the diet needed to assess the adverse effects of short term HFD-feeding on the 
hippocampus. 
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Considerations for Designing Studies Investigating Short-term HFD-feeding 
effects on the Hippocampus 
At the start of our study, the shortest high-fat diet duration to report 
neuroinflammatory changes within the brain was 8 weeks [47,48] which was used in 
determining the experimental protocol.  A more recent study reported changes in pro-
inflammatory cytokine expression after 1 and 3 days of HFD-feeding [58]. 
However, the Milanski (2009), Moraes (2009), and Thaler (2011) studies reported 
changes within the hypothalamus, an area of the brain relatively unprotected by the blood 
brain barrier (BBB).  Diet-induced neuroinflammation and microglial activation in the 
hypothalamus could be important factors in the development of nutritional diseases such as 
obesity, insulin resistance, or leptin resistance.  Though these risk factors are associated with 
AD development, the hypothalamus is not a brain area directly related to cognitive 
impairment or AD pathology.  In order to study implications of short-term HFD-feeding on 
neuroinflammation in relation to potential causes of AD, we assessed inflammatory markers 
within the hippocampus, a region of the brain directly related to cognition. 
The BBB is a physical, protective barrier between cerebral blood vessels and areas of the 
CNS.  In contrast to hypothalamic areas of the brain, in which the BBB is “leaky” [106], the 
BBB regulates the entrance of specific molecules, including dietary fatty acids, into the 
hippocampus, indicating that short-term feeding effects like those seen in the Thaler study 
(2011), may be more difficult to evaluate [58].  Many dietary fatty acids, including SFAs, 
need prolonged exposures to cross the barrier.  The BBB poses a potential obstacle in 
designing studies investigating acute HFD effects on hippocampal neuroinflammation, as 
well as other measures within the hippocampus.  If the BBB regulates the entrance of certain 
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types of dietary fats, then an optimal diet duration exists for observing the effects of specific 
dietary fats on neuroinflammation, while minimizing the effects associated with HFD- 
induced obesity.  This research question has important implications in interpreting the data. 
Research investigating fatty acid transport through the BBB is sparse.  The 
mechanism that regulates the transport of fatty acids across the tight junctions of the BBB is 
still unknown.  Two prevailing theories are (1) passive diffusion using a “flip-flop” 
mechanism independent of protein-mediated transport and (2) protein-mediated fatty acid 
transport [46].  Passive diffusion would entail fatty acids separating from albumin at the 
BBB, since most proteins do not readily pass through the BBB’s tight junctions.  Upon 
separation from albumin, evidence supports the notion that the free fatty acid moves through 
the BBB in a transmembrane, “flip-flop” manner.  In contrast, the active transport theory 
could include specific protein transporters including fatty acid transport proteins 1-6 (FATP 
1-6), fatty acid translocase/CD 36 (FAT/CD36), and/or a variety of fatty acid binding 
proteins (FABPs).  Though short and medium chain fatty acids, less than 12 carbons in 
length, move readily across the BBB, transport of long chain fatty acids, such as palmitic, 
stearic, or linoleic acid, is likely more regulated.  FATPs and FAT/CD36 have high affinities 
for long-chain fatty acids such as palmitic or stearic acid, and are expressed in neural tissue.  
FABPs, specifically FABP7, which is expressed in the brain, have high affinities for 
polyunsaturated fatty acids such as docasahexaenoic acid (DHA) or ω-6 PUFAs such as 
linoleic acid [46]. 
Studies have explored the capacity for BBB penetration of certain types of dietary 
fats.  A study conducted by Edmond et al. (1998) reported that perdeuterated
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 polyunsaturated fatty acids, particularly linoleic acid but also other ω-6 PUFAs, were readily 
transported into the developing brains of Sprague-Dawley rats.  In addition, the brain is 
enriched in polyunsaturated fats, which are utilized for essential components i.e. structural 
membranes of brain cells.  Edmond et al. (1998) also reported that in young, developing rats, 
perdeuterated monounsaturated and saturated fats did not cross the BBB [92].  In another 
experiment utilizing primary brain microvessel endothelial cells, Mitchell et al. (2011) 
reported that oleic acid (MUFA) was actively transported.  In addition, RNA interference of 
FATP-1 or FAT/CD36 significantly prevented the transport of oleic acid.  Taken together, 
research suggests that a combination of passive diffusion and active transport is likely 
involved in the process of fatty acid uptake into the brain [46].    
Several reports have indicated that prolonged feeding exposure to a Western Diet 
(WD) increases BBB permeability [30].  The WD used in the Kanoski and Davidson study 
(2011) was high in both saturated fatty acids and simple sugars.  Other reports have indicated 
that prolonged exposure to LPS can also increase BBB permeability, and several similarities 
exist between molecular structures of LPS and SFAs [30,94].  If the BBB becomes more 
permeable, hypothetically, increased SFA penetrance through the BBB would allow effects 
of HFD-feeding on potential cytokine production.  Though transport of long-chain SFAs 
across the BBB is highly debated, HFDs, specifically high in saturated fats, have reported 
detrimental effects in cognition, neuroinflammation, and AD development.  Changes in the 
BBB may allow for HFD effects to take place.  To date, the proper diet duration to affect 
hippocampal neuroinflammation from acute HFD-feeding remains unknown 
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Effects of Short-term HFD-feeding on Neuroinflammation in the Hippocampus 
 Results from this study, specifically in C57BL/6 mice, indicate that 8 weeks of HFD-
feeding is sufficient to increase TNF-α expression, a pro-inflammatory cytokine, in the 
hippocampus.  In addition to increases in TNF-α expression, significant decreases were 
found in IL-10 expression, an anti-inflammatory cytokine.  The combination of increased 
TNF-α expression and decreased IL-10 expression results in an increased neuroinflammatory 
state within this region of the brain.  Cytokine production at the protein level within the 
hippocampus was not directly measured; however, transcriptional changes indicate an effect 
of HFD-feeding on activation of an inflammatory signaling pathway.  Though 8 weeks of 
HFD-feeding limited obesogenic effects of the diet, C57BL/6 mice fed the HFD gained 
significantly more weight than their LFD-fed controls.  Some of the effects reported may be 
due to changes related to diet-induced weight gain/obesity, rather than acute effects of the 
HFD.  
Other studies have also utilized 8 weeks to assess changes in the hippocampus; 
however, either in different models or with very different diets.  A 2008 study conducted by 
Thirumangalakudi et al. (2008) investigated the effect of a high-fat/high-cholesterol diet 
(1.25% cholesterol) compared to normal chow (0.05% cholesterol) in C57BL/6 mice LDLR 
WT, non-transgenic mice, as well as LDLR -/- and PDGFB-App
wt
 mice.  Thirumangalakudi 
and co-researchers (2008) reported that C57BL/6 mice fed the high-fat/high-cholesterol diet 
for 8 weeks had increased TNF-α, IL-1β, IL-6, Nitric oxide synthase 2, and COX-2 
expression in the hippocampus.  The increase in neuroinflammation was accompanied by 
increased microglial and astrocyte activation, and these high-fat/high-cholesterol fed 
C57BL/6 mice were deficient in handling an increasing working memory load [72].   
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Another study conducted by Granholm et al. (2008) used a similar dietary strategy as 
the Thirumangalakudi study (2008), but in 16 month old Male Fischer rats.  They used a high 
saturated fat diet that consisted of 2% cholesterol and 10% hydrogenated coconut oil 
compared to 12% soybean oil.  Like in the Thirumangalakudi study (2008), Granholm et al. 
(2008) also reported increased microglial activation in the high saturated fat fed group, in 
addition to impairment in the cognition tests.  Both studies utilized diets that were very 
different from our study, but indicated that 8 weeks is sufficient to detect neuroinflammatory 
effects of relatively, high-fat feeding [62]. 
Though reports of short-term HFD-feeding effects on neuroinflammatory changes in 
the hippocampus are limited, the Thirumangalakudi (2008) and Granholm (2009) studies 
indicated that diet durations of 8 weeks, an equivalent diet duration to our study, generated 
comparable results.   
Studzinski et al. (2009) also investigated the short-term effects of HFD-feeding, 
specifically a 40% kcal from fat Western Diet for only 4 weeks, on oxidative stress and Aβ 
levels in the hippocampus.  Studzinski and co-researchers (2009) used AD mouse models 
including a Cre-lox knock in of mutated, “humanized” APP and PS1 genes on a C57BL/6J 
background compared to wild-type (WT), non-transgenic littermates.  Studzinski et al. (2009) 
reported that after only 4 weeks of HFD-feeding, both mouse strains, transgenic and WT 
mice, had significantly increased oxidative stress as measured through lipid hydroperoxides 
in the hippocampus.  Oxidative stress is often accompanied by heightened levels of 
inflammation, indicating that the results of our study could be consistent with this report [71].  
In addition, after 4 weeks of HFD-feeding both mouse strains had significantly increased 
weight gain, fasting glucose, and resistin levels.  Plasma insulin, leptin, and adiponectin were 
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not significantly changed; however, Studzinski noted an upward trend in plasma leptin in 
HFD-fed mice.  Like in the present study, Studzinski et al. (2009) were unable to fully 
separate the effects of short term WD-feeding from possible obesogenic effects.  No changes 
in Aβ levels in either mouse type after only 4 weeks were reported [71], which suggests that 
HFD-effects on oxidative stress may precede alterations to Aβ levels in the hippocampus, 
even in genetically-predisposed mice. 
Effects of Short-term HFD-feeding on Microglia 
Another main finding of the C57BL/6 experiment presented herein was that 8 weeks 
of HFD-feeding increased the number of microglia expressing TLR-2 and TLR-4/MD-2 in 
whole-brain tissue.  These toll-like receptors respond to various pathogen-associated 
molecular patterns (PAMPs) as part of the innate immune system [34].  It has been 
hypothesized, that in addition to recognition of PAMPs that are associated with bacterial, 
viral, and fungal pathogens, these receptors also can be activated through binding of SFAs 
[39,41,44,47].  Our data clearly indicated that the HFD upregulated the expression of these 
receptors and a greater number of microglia would potentially respond to TLR-2 and TLR-4 
ligands.   
In the C3H experiment, TLR-2 and TLR-4 was also upregulated by 8 weeks of HFD-
feeding; however, this upregulation was only present in the C3H/HeN mice.  This result 
suggests that HFD-induced TLR-2 and TLR-4 upregulation is mediated through TLR-4 
signaling.  Another study also reported that TLR-2 expressed on endothelial cells was 
upregulated in a TLR-4 dependent manner through neutrophil NADPH oxidase [93].  An 
unexpected finding in the C3H experiment was that even though TLR-2 and TLR-4 receptors 
were upregulated on the microglia isolated from whole brain tissue of HFD-fed C3H/HeN 
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mice, the microglial inflammatory response upon LPS stimulation was significantly 
decreased.  In support of this finding, there was a lack of increased neuroinflammation in the 
HFD-fed C3H/HeN mice in the PCR data.  It may be possible that downstream signaling 
molecules of the TLR-2 and TLR-4 pathways were downregulated as a result of 8 weeks of 
HFD-feeding in the C3H/HeN mice.  Further study would be needed to elucidate this finding. 
Both the Milanski (2009) and Moraes (2009) articles also assessed TLR-2 and TLR-4 
levels, as well as activation of microglia; however, in contrast to our study which assessed 
these markers in C57BL/6 and C3H mice, both Milanski (2009) and Moraes (2009) assessed 
these changes in Wistar rats [47,48].  Moraes and co-investigators (2009) demonstrated that 8 
weeks HFD-feeding with 55% kcal from lard was sufficient to increase levels of TLR-4 
expression in hypothalami from Wistar rats, as well as F4/80, a glial cell activation marker 
[48].  Milanski et al. (2009) demonstrated that acute intracerebroventricular administration of 
arachidic acid resulted in increased TLR-2/MyD88 and TLR-4/MyD88 
associations/activations in the hypothalami of Male Wistar rats [47].  The Granholm (2009) 
and Thirumangalakudi (2008) studies also reported increased microglial activation through 
immunohistochemical staining, indicating that HFDs results in increased microglial 
activation across several different rodent models [62,72].   
Effects of Long-term HFD-induced Obesity on Neuroinflammation  
 As mentioned, it is often difficult to separate the effect of obesity from the acute 
effects of HFD on neuroinflammatory changes within the hippocampus.  Both the Studzinski 
paper (2009) and our study limited these potential obesogenic effects on hippocampal 
neuroinflammatory markers [71].  However, in both models, significant weight gain occurred 
as a result of HFD-feeding.  Obesity is associated with many physiological changes that have 
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a wide array of adverse effects on organs of the body and increases the risks of chronic 
diseases such as type 2 diabetes mellitus and heart disease. 
One of the main findings in the C57BL/6 mice was increased TNF-α expression in 
the hippocampus.  TNF-α is a potent pro-inflammatory cytokine and adipokine that is 
normally increased with higher adiposity.  TNF-α plays an important role in initiating and 
regulating the cytokine cascade during an inflammatory response, mediated through NF-κB 
activation [107].  In addition, increased TNF-α expression is associated with increased AD 
risk and is found in the brains of AD patients.  TNF-α also has been reported to increase BBB 
permeability [94], which in turn will increase the amount of TNF-α that can enter the brain 
after a given exposure time.  It may be possible that some or all of the observed increases in 
TNF-α expression were the result of changes in peripheral inflammation.  A future study 
could assess serum levels of TNF-α between different treatment groups.  In order to separate 
effects of peripheral TNF-α expression on hippocampal TNF-α expression from hippocampal 
TNF-α expression due to HFD, a neutralizing anti-TNF antibody could potentially be used by 
injecting into peripheral circulation [95]. 
Though 8 weeks of HFD-feeding is a relatively short period for inducing obesity, 
studies investigating the effects of long-term HFD-induced obesity on various 
neuroinflammatory markers and cognition have shown clear detrimental effects over the long 
run.  Long-term diet feeding introduces more potential factors into the development of both 
neuroinflammation and AD pathologies; however, they may also be representative of the 
etiology of AD, which occurs over a full life-time and is generally manifested after 65 years 
of age [22,25,67,69,70,74,86,].   
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Boitard et al. (2012) fed both weanling 3 week-old C57BL/6J and 12 week-old 
C57BL/6J mice either a standard chow diet (CD) consisting of 3 g% (approximately 6.5% 
kcal) from fat or a high-fat diet (HFD) (D#12451, Research Diets) consisting of 45% kcal 
from fat diet for 11 weeks.  The high-fat diet used in this study was the same high-fat diet 
used in our work.  Boitard and co-investigators (2012) tested mice in a two-stage relational 
memory flexibility arm maze test after 11 weeks of HFD-feeding.  In addition, they also 
measured doublecortin (DCX) levels, an endogenous marker of newborn neurons, in dentate 
gyrus of the hippocampus.  After 11 weeks of HFD-feeding, all HFD-fed treatment groups 
gained significantly more weight. Boitard et al. (2012) found that more weanling C57BL/6J 
mice were unable to habituate to the first stage of the relational memory flexibility test than 
the other 3 treatment groups.  These mice were subsequently excluded from the second stage 
of testing.  In the second stage of the behavioral test, they found of the mice that remained, 
weanling C57BL/6J mice were less able to associate visual cues in similar, but slightly 
different, arms of the maze.  This indicated impairment in relational memory flexibility in 
HFD-fed, weanling C57BL/6J mice compared to CD-fed controls.  These two behavioral 
findings were further supported by the finding that there was a significant decrease in DCX, 
indicating less neurogenesis, in the HFD-fed, weanling C57BL/6J mice compared to CD-fed 
controls.  Neurogenesis is important in both development and cognitive ability.  There were 
no differences between CD and HFD-fed adult C57BL/6J mice in any of the tests.  This 
study conducted by Boitard et al. (2012) indicates that the age of the mice upon HFD-feeding 
is important in determining both neuronal and behavioral consequences [74]. 
Hwang et al. (2009) fed both weanling C57BL/6N and C3H/HeN mice either a low-
fat diet (4.2% fat by weight) or a high-fat diet (34.9% fat by weight) for 12 weeks.  Hwang 
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and co-researchers (2009) reported that HFD-fed C57BL/6N mice were more susceptible to 
body weight gain and lipid peroxidation in the CA1 region of the hippocampus than the 
LFD-fed C57BL/6N, LFD-fed C3H/HeN, or HFD-fed C3H/HeN mice.  Lipid peroxidation is 
often accompanied by increased neuroinflammation.  Given the similar design with 
differences mainly in diet duration, it is not surprising that the results in Hwang et al. (2009) 
would be in agreement with our data, which showed increased hippocampal 
neuroinflammation in the HFD-fed C57BL/6 mice; however, we were unable to replicate this 
increase in the C3H/HeN mice fed the same diet [86].   
Another study conducted by McNay et al. (2010) fed Sprague-Dawley rats on either 
standard chow or a high-fat diet (31.8% kcal by butter and corn oil) for 14 weeks and tested 
cognitive performance.  McNay et al. (2010) reported that HFD-feeding, in the presence of 
hyperinsulinemia or increased body mass, impaired cognition in several behavior tests.  
McNay (2010) also reported that HFD-feeding, in the absence of hyperinsulinemia or 
increased body mass, did not cause cognitive impairment and that microinjections of insulin 
into the hippocampal region improved cognitive performance in obese, cognitively impaired 
rats.  These findings indicated an important role of insulin in the memory process [67]. 
A study conducted by Puig et al. (2011) fed 6 week old C57BL/6J mice either a high-
fat diet (21.2% fat by weight) or a low-fat control diet (5.5% fat by weight) for 22 weeks.  
Puig and co-researchers reported diet-induced obesity contributed to increased TNF-α and 
activation of microglia and macrophage in both adipose tissue and hippocampal brain tissue, 
respectively.  In addition, these pro-inflammatory changes were accompanied by increased 
brain levels of APP.  The results in the Puig study (2011) agree with our hippocampal 
C57BL/6 data [70].   
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A study reported by Morrison et al. (2010) investigated the effects of a Western Diet 
(WD), a high-fat lard (HFL) diet, or corresponding low-fat control diets on hippocampal 
oxidative stress and cognition in “aged” mice.  They fed 20 month old C57BL/6 mice the 
diets for 16 weeks.  Morrison and co-researchers (2010) reported that even though both the 
WD and HFL treatment groups had increased body weight, adiposity, and fasting glucose, 
only the HFL group had increased age-related oxidative damage and impaired retention in 
behavioral testing [69].  Another study conducted in the same lab led by Pistell et al. (2010) 
tested middle-aged, 12 month old C57BL/6 mice with the same WD and HFL diets used in 
the Morrsion study (2010) for 21 weeks.  The Pistell study (2010) reported that both WD and 
HFL treatment groups had increased body weight and astrocyte reactivity, but only the HFL 
group had increased cytokine production, impaired cognition, and decreased brain-derived 
neurotrophic factor (BDNF) [25].  Our diet was most similar to the WD used in this study, 
though differences did exist in the fat composition between each diet.  Their findings when 
compared to our findings confirm that the age of the mice upon dietary treatment and diet 
durations is important in determining the neuroinflammatory effects, because we observed 
neuroinflammatory effects in our weanling C57BL/6 mice after only 8 weeks, whereas a 
similar diet was ineffective in increased neuroinflammation in older mice over a longer, 
dietary duration.   
Additional studies have investigated the effects of very long-term HFD-feeding. 
Hwang et al. (2009) placed 3 week-old weanling male and female C57BL/6J mice on either a 
normal chow or a HFD for a 9 to 12 month dietary period.  Hwang et al. (2009) reported that 
male mice were more vulnerable to the effects of the HFD.  Obese male mice developed 
hypercholesterolemia, hyperglycemia, hyperinsulinemia, and hyperleptinemia, but not 
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hypertriglyceridemia.  The obese female mice had less hypercholesterolemia and 
hyperinsulinemia than the obese males.  In addition, obese male mice on a HFD had 
decreased learning performance compared to LFD-fed, normal controls.  The decreased 
learning performance in HFD-fed obese males corresponded to impaired synaptic plasticity 
[22]. 
Another study conducted by Farr et al. (2008) fed 8 week old CD-1 male mice for 10 
months on either a 5% fat regular chow or a 10% fat diet.  The investigators determined 
obesity status based on more than a 30% weight gain over the feeding period.  The obese 
CD-1 male mice had hypertriglyceridemia.  Farr and co-researchers reported that obese CD-1 
male mice displayed impaired acquisition in 3 different cognitive paradigms, and when 
triglycerides were lowered through administration of the drug, gemfibrozil, cognition was 
improved, indicating a potential role of hypertriglyceridemia in cognitive performance.  Both 
studies investigated the effects of very long-term HFD-feeding, which may be representative 
of the long-term exposure of HFDs in contributing to increased AD risks, as reported in 
human epidemiological studies [21]. 
 In addition to normal mouse and rodent models, i.e. C57BL/6 male mice, several 
studies previously mentioned investigated the effects of HFD-feeding and diet-induced 
obesity in AD mouse models.  The Studzinski article (2009) used a humanized double-
mutant of both the APP and PS-1 gene, both genes with implications in AD development.  
Studzinski and authors found that even though both models exhibited detrimental effects of 4 
weeks of HFD-feeding, that the double-mutant exhibited the highest levels of lipid 
peroxidation.  They also found that the changes in oxidative damage preceded the formation 
of Aβ plaques [71].  Another study conducted by Fitz et al. (2010) fed 9 month old APP23 
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mice, a transgenic AD mouse model on a C57BL/6 background, with a high fat/high 
cholesterol diet for 4 months.  Fitz et al. (2010) demonstrated that high-fat feeding 
exacerbated cognitive performance, increased amyloid load, and increased insoluble Aβ 
levels.  In both studies, HFD exacerbated AD pathologies in the AD mouse models indicating 
a potential role of HFD in AD pathogenesis [61]. 
The review of these mouse and rodent reports, partly summarized in Table 2, clearly 
indicates that high-fat feeding for periods of several weeks can lead to increased 
neuroinflammation in the hippocampus, impaired cognition, and can lead to pathology 
similar to neuronal changes observed in Alzheimer’s disease.  In addition, the effects of 
HFD-feeding are altered by numerous factors including, but not limited to, genetics, dietary 
composition of the HFD, dietary exposure time, and the age at exposure.  Each of these 
factors can contribute to different results.   
Differences between C57BL/6 mice and C3H mice in response to HFD-feeding 
 Several studies have reported a role of TLR-4 in mediating HFD-induced 
inflammation.  The Milanski study (2009) reported that loss of TLR-4 activity in C3H/HeJ 
mice largely prevented increases in neuroinflammation within the hypothalamus [47].  In 
order to investigate how TLR-4 could mediate the observed neuroinflammation in the 
hippocampus, we utilized the same C3H/HeJ mice and their respective TLR-4 intact controls, 
C3H/HeN mice.   
After 8 weeks of HFD-feeding, we were unable to replicate the increased 
hippocampal neuroinflammation reported in the C57BL/6 mice in the C3H/HeN mice.  We 
hypothesized that C3H/HeN mice, which have intact TLR-4 signaling, would have had 
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comparable results to the C57BL/6 mice.  In addition, we observed decreased 
neuroinflammation in the hippocampus of the C3H/HeN mice, specifically decreased IL-6 
expression, and the results indicated that TLR-4 may have mediated this HFD-effect.  
Differences in the results between the C57BL/6 mice and the C3H mice imply that these two 
mouse models may have reacted differently to the experimental diet, because of unexplained 
genetic and/or environmental factors.   
That two different mouse models would have experienced different effects of the 
same HFD was not unexpected.  Inbred mouse strains can react differently given similar 
experimental conditions.  C57BL/6 mice have been characteristically used in studies 
investigating the effects of diet-induced obesity (DIO), as well as HFD-induced 
diabetes/insulin resistance studies, because of their propensity to gain weight and become 
insulin resistant.  In addition to a propensity for developing associated risk factors of AD 
from HFD-feeding, C57BL/6 mice have also successfully been used to demonstrate HFD- 
induced neuroinflammation in the hippocampus in many different experimental set-ups 
[64,69,70,72,74,86].  In future studies investigating the role of TLR-4 in mediating HFD-
induced neuroinflammation in the hippocampus, a TLR-4 knock-out on a C57BL/6 
background might be employed.  Increased expression of neuroinflammation has been 
reported in AD patients [90].  The C57 mouse model may be a more suitable model than the 
C3H mouse model for representing relative short-term HFD-feeding effects on hippocampal 
neuroinflammation. 
 It appears that the brain of C3H mice are more protected against the acute effects of 
HFD-feeding, despite increases in peripheral inflammation as we reported in liver (data not 
shown) and isolated splenocytes.  The Hwang study (2009) also reported that C3H/HeN mice 
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were more resistant to weight gain, oxidative damage, and microglial reactivity than 
C57BL/6N mice following 12 weeks of HFD-feeding.  Given our results as well as the 
comparative analysis conducted by Hwang et al. (2009), definitive differences between the 
two mouse models in studying the effect of HFD on hippocampal neuroinflammation were 
evident [86]. 
This major difference in model responses to HFD is further supported by comparative 
studies investigating the effects of different infection models on both C3H/HeN and 
C57BL/6 mice.  For example, a study conducted by Packiam et al. (2010) reported that both 
Balb/C and C57BL/6 mice were susceptible to Neisseria gonorrhoeae infection that resulted 
in increased cytokine production; however, these authors reported that C3H/HeN mice were 
resistant to infection with N. gonorrhoeae [96].  Many studies have compared C3H and C57 
mice in different infection models of Chylmadia, with several reporting increased 
susceptibility in C3H mice [97,98].  In one study, however, the C3H mice did not produce as 
much TNF-α as the C57 mice, which the authors believed may have resulted in increased 
susceptibility to infection [97].  Genetic strain clearly plays a large role in determining the 
host response to certain pathogenic stimuli, including the induction of cytokine expression.   
Another difference between these two mouse strains was their origin.  C57BL/6J 
mice were purchased from Jackson Laboratories, whereas C3H mice were obtained from 
NCI.  Both mouse strains were placed on the experimental diets at weanling, which was 3 
weeks for C3H mouse strains and 4 weeks for C57BL/6J mice.  It is possible, but unlikely, 
that the difference in age at weanling contributed to differences in neuroinflammatory 
response utilizing the same diets.  It is more likely that differences occurred in how each 
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laboratory housed the dams for the two mouse types.  Maternal diet can affect brain 
development during both pre-natal and post-natal, weanling periods.   
 One study conducted by Ranade et al. (2008) investigated the effects of three types of 
malnourishment diets (caloric restriction, low in protein, and low in iron content) on 
hippocampal development in Swiss albino mice.  Ranade et al. (2008) reported that 
hippocampal sub-regions of the F1 generation were differentially vulnerable to changes in 
hippocampal volume, depending upon the particular malnutrition diet.  Ranade et al. (2008) 
also reported that the volume differences in the hippocampal sub-regions of the F1 progeny 
corresponded with differences in working memory errors in behavioral testing.  This study 
demonstrated that differences in diets can have different effects on hippocampal development 
[99].  It is not likely that either facility providing mice fed maternal diets to C3H or C57 
dams that may have malnourished the pups; however, if the dietary composition was 
different in each group, developmental differences may have resulted.   
Another study conducted by Tian et al. (2011) specifically addressed the effects of 
maternal diet differences in the ω-6/ω-3 PUFA ratio on brain development.  Different ω-6/ω-
3 PUFA ratio diets were given 2 months before conception and through the lactation period.  
Tian et al. (2011) reported that each diet produced different expression of several brain 
developmental genes, and that diets highest in ω-3 PUFAs may have been beneficial for early 
brain development [100].  Though previous studies are lacking, investigation of the particular 
effects of standard maternal mouse diets on brain development or brain lipid profiles across 
different mouse strains are needed.  A future study might investigate how small differences 
inherent in breeding colonies maintained by different facilities could affect different brain 
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studies including developmental changes, brain lipid profiles, as well as later responses to 
experimental stimuli.   
Differences between our results and the reported results of the Moraes study (2009) 
and the Milanski study (2009) require further examination.  Moraes et al. reported increased 
inflammation and apoptotic gene expression in the hypothalamus of C3H/HeN mice after 8 
weeks of HFD-feeding, and the Milanski article (2009) reported protection from DIO in the 
C3H/HeJ mice [47].  We were unable to replicate either result.  Though Moraes et al. (2009) 
and Milanski et al. (2009) utilized similar HFDs to the one employed in this study, they both 
compared to standard rodent chows [47,48].  Our comparisons were made against a more 
relevant, low-fat defined control diet.  The fat source used in our HFD and LFD were the 
same, whereas the fat, protein, and carbohydrate sources in their LFD controls could have 
been different from their experimental HFDs.  Controlling for the type of fat source in the 
LFD would likely limit differences seen between the two treatment groups, in comparison to 
the diets used in the Milanski (2009) and Moraes (2009) studies.  In addition, the age of the 
C3H mice used in the Milanski (2009) and Moraes (2009) studies were older, both 8 weeks 
old as compared to the 3-week old, weanling mice that were used in this study [47,48].  
Developmental differences in the mice may have existed in the studies, as was demonstrated 
in the Boitard et al. study (2012) that could have affected comparisons of the research data 
[74]. 
Even though BBB permeability was not measured in either the C57 or C3H mice, one 
may postulate that the increased SFAs present in the HFD were able to enter the 
hippocampus of the C57 mice, but not the C3H mice, which would in part explain the
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differences in the effects of the diets.  As mentioned previously, a limited number of studies 
investigating fatty acid uptake in the brain exist, but the limited evidence that has been 
presented implies that PUFAs are readily taken up, whereas SFAs may only pass through 
BBB when it becomes leakier.  In addition to increases in SFA content, the HFD used in our 
experiments with the C57 and C3H mice were particularly high in PUFAs, which have been 
reported to have some anti-inflammatory, neuroprotective effects [23,101,102].  The results 
reported for the C3H mice may reflect only the neuroprotective effects of PUFAs, and that 
SFAs were not readily taken up into the hippocampus; whereas for the C57BL/6 mice, 8 
weeks was sufficient to allow SFAs to enter the hippocampus and increase 
neuroinflammation.  One of the research questions that might be tested by another 
experiment would be if genetic strain or weanling age of the mice affects fatty acid uptake 
into the brain on experimental HFDs.  A labeling experiment utilizing perdeuterated fatty 
acids could be employed in a time-course dependent manner to test the capacity for specific 
types of fatty acids to transport across the BBB into the hippocampi of different inbred 
strains over time. 
 The C3H model was unsuccessful in replicating and investigating the role of TLR-4 
in HFD-induced neuroinflammation; however, it did provide some interesting results that add 
further support investigating the potentially neuroprotective effects of ω-6 PUFAs.  Though 
these particular ω-6 PUFAs, i.e. linoleic acid, have been hypothesized to be pro-
inflammatory through increased production of prostaglandins, leukotrienes, and 
prothromboxanes, associations have been previously reported in epidemiological studies 
between increased ω-6 FA intake with decreased AD risk.  The experimental diet utilized in 
our study had particularly increased linoleic acid content as reported in Table 3 in appendix. 
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A human study conducted by Morris et al. (2003) examined the associations between 
intake of different types of dietary fats with incidence of AD in Caucasian and African-
American populations.  Morris (2003) reported increased AD risk with increased dietary 
intake of saturated and trans-unsaturated fats, whereas there was a decreased AD risk with 
increased intake of monounsaturated and ω-6 polyunsaturated fats.  Furthermore, Morris et 
al. (2003) reported an inverse linear association between AD risk and intake of vegetable fat 
(p = 0.002), and after adjusting for specific types of fats, a marginally significant inverse 
linear association was found between ω-6 PUFAs and AD risk [23].  In addition, animal 
studies have indicated that feeding with higher amounts of omega-6 PUFAs is protective 
against clinical incidence and histological manifestations of experimentally-induced 
autoimmune encephalomyelitis (EAE) [101] .  Omega-6 fatty acids, specifically 
supplemental linoleic acid, were reported to be protective in human cases of multiple 
sclerosis [102].  Therefore, though studies are limited, some beneficial effects of ω-6 fatty 
acids have been noted in the brain. 
Future Studies and Implications of Our Findings 
 Further study and experimentation is needed to elucidate several of the findings 
reported in this study.  Testing tissues of C57 and C3H mice concordantly would be useful, 
which could allow to control for as many environmental factors as possible.  Body weights 
and age of the mice should be held within a limited range of each other at the start of the 
study; however, inherent differences always exist between strains.  In addition to replicating 
the data, a third treatment group of TLR-4 knockout mice on a C57BL/6J background could 
be used to test the functional role of TLR-4 in mediating increased neuroinflammation in the 
C57 strain.  Data from this experiment would likely demonstrate differences between the 
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strains after 8 weeks of HFD-feeding and a role of TLR-4 in HFD-induced TNF-α expression 
in the C57 mice. 
Serum leptin and resistin levels were measured in the C3H mice; however, additional 
serum measurements would be useful.  Serum leptin and resistin levels should be measured 
in the C57 mice to make comparisons between strains.  In addition, insulin plays important 
roles in the etiology of AD, memory processing, and obesity [13].  Insulin has also been 
reported to modulate the innate immune response and cytokine expression levels in several 
different models [103,104].  Serum insulin should be measured in all treatment groups, which 
may provide important information as to why differences in inflammatory response were 
seen between the two mouse models.  A likelihood of differences in serum insulin will exist 
due to the propensity for C57 mice to develop insulin resistance after HFD-feeding. 
Downstream insulin signaling in all the treatment groups may also provide interesting data.  
In addition, as mentioned previously, a measurement of serum TNF-α and IL-6, and possibly 
other markers, may be important in all treatment groups. 
Another key aspect of the mice which was not studied in the present experiment was 
the lipid profile of the mouse, both in the periphery and the brain.  Lipid profiles would be an 
important variable because of differential effects on tissues.  High-fat diets are known to 
affect peripheral lipid profiles.  Docosahexaenoic acid, arachidonic acid, linoleic acid, and α-
linolenic acid can all have major effects on brain lipid profiles during development [105]; 
however, there are far less studies investigating and reporting changes in brain lipid profiles 
as a result of increased dietary intake of saturated fatty acids.  If brain lipid profiles differ 
between LFD-fed and HFD-fed mice in the hippocampus, this could contribute to potential 
differences in effects.  There could also be differences in brain lipid profiles at baseline 
 65 
 
 
between each genetic strain.  Tissue lipid profiles may differ over time, as the BBB changes 
with prolonged exposure to the HFD. 
Even with several uncertainties, the data from this study can be extrapolated to the 
human population.  First of all, in the C57BL/6 mice, we demonstrated that even short-term 
HFD-feeding can be detrimental and have consequences.  Neuroinflammation can lead to 
increased neuronal death, and after only 8 weeks of HFD-feeding, increased levels of 
neuroinflammation were found in the hippocampus.  The fact that short-term feeding can 
have effects within the hippocampus implies that dietary interventions against detrimental 
diets and transitions to potentially beneficial diets could positively affect AD-prone 
individuals. 
A major finding of this paper seems is that genetic strain of the mice can play a large 
role in determining the outcome of a particular diet on neuroinflammation, which is a known 
risk factor for the development of neurodegenerative disease.  In addition, it is well 
established that certain genetic factors predispose individuals to be more at risk for AD later 
in life.   
For at-risk individuals, it may be possible, with more supportive data, to design diet 
plans to limit risk for AD.  For instance, for individuals carrying the APOE ε4 
polymorphism, dieticians may promote diets that are low in fat, particularly in SFAs.  Also, 
considering epidemiological data as well as some of the data presented in both the C57 and 
C3H mice, dieticians may want to promote a transition between the types of fats an at-risk 
individual may consume towards a diet higher in PUFAs than SFAs.  Still, much remains to 
be learned, but early indications tend to support the notion that individuals with dietary 
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intake lower in SFAs tend to have better health outcomes including decreased AD risk.  As 
more data begin to accrue, especially mechanistic data from animal models, new dietary 
strategies can be designed that will ultimately decrease the incidence of AD.   
  
 
6
7 
Investigators Mouse/Rodent 
Model 
Diet Relevant Findings 
Thaler et al. (2011) Weight-matched 
Male Long-Evans 
Rats, weight-
matched male 
C57BL/6 (ages 
unspecified) 
Standard lab chow (PMI Nutrition 
International), high-fat diet 
containing 60% kcal fat 
(D#12492, Research Diets) 
 
Duration:  Various with 1d, 3d, 
7d, 14d, 28d, 4 weeks, 20 weeks 
In Long-Evans rats 
 4 and 20 weeks of HFD-feeding caused increased proinflammatory 
cytokine expression in hypothalamus, but 4 weeks was not sufficient 
to increase liver or adipose tissue inflammation 
 HFD-feeding acute time course experiment indicates an “on-off-on” 
pattern of hypothalamic cytokine expression with increased TNF-α, 
IL-6, and Ikbkb at 1d, increased IL-6, SOCS-3, Ikbkb, and Ikbke at 
3d, decreased Il-1β at 7d, increased Ikbkb at 14d, and increased 
TNF-α, IL-6, SOCS-3, Ikbkb, and Ikbke expression at 28d 
 Microglial activation markers were increased in accordance with 
cytokine induction with increases at 1d, 3d, 14d, and 28d 
 Immunohistochemistry with Iba-1 indicated that activation of 
microglia after 3d 
In C57BL/6 mice 
 Proinflammatory cytokine expression in hypothalamus followed a 
similar expression pattern during the first 7 days of HFD-feeding 
Studzinski et al. 
(2009) 
1 month old APP 
X PS1 transgenic 
mice, 1 month old 
C57BL/6 WT 
littermates 
Standard chow containing 10% 
fat (Diet #98052602), typical WD 
mix containing 40% fat (Diet 
#D12079B) 
 
Duration:  4 weeks 
 WD resulted in increased protein carbonyls, protein nitrosylation, 
and lipid hydroperoxides in both WT and APP X PS1 mice 
hippocampi, with the highest levels of each oxidative stress marker 
in hippocampi of APP X PS1 mice 
  WD did not increase soluble or insoluble Aβ levels in either mouse 
strain  
Thirumangalakudi et 
al. (2008) 
4 month old 
C57BL/6J mice, 4 
month old LDLR 
-
/-
 mice 
Normal chow (5% fat and 0.05% 
cholesterol), High fat/high-
cholesterol (21% fat and 1.25% 
cholesterol) 
 
Duration: 8 weeks 
C57BL/6J mice fed the high-fat/high-cholesterol diet  
 Were deficient in handling increased working memory loads 
compared with controls 
 had increased microglial and astrocyte activation 
 had increased TNF-α, IL-1β, IL-6, Nitric oxide synthase-2, COX-2, 
and β-site APP cleaving enzyme 1 
Moraes et al. (2009) 8 week old Male 
Wistar Rats, 8 
week old 
C3H/HeN mice, 8 
week old 
C3H/HeJ mice, 8 
week old Swiss 
Standard chow (9% kcal saturated 
fat), High-Fat chow (HF) (55% 
kcal saturated fat) 
 
Duration:  8 weeks 
In Male Wistar Rats 
 HF diet led to increased hypothalamic expression of TNF-α, IL-1β, 
IL-6, protein levels of SOCS-3, pJNK, pIKK, and glial cell 
activation marker F4/80.   
In C3H/HeJ mice  
 gained significantly less weight than C3H/HeN mice 
 Increased expression of Bax, association of APAF1 with caspase-9, 
Table 2.  Summary of Cited Studies Investigating Effects of High-fat Feeding on Neuroinflammation and Cognition 
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mice association of FADD with caspase-8, and decreased Bcl-2.   
 Increases in pro-apoptotic markers in C3H/HeJ mice were 
accompanied by ER stress markers pPERK and pJNK. 
Milanski et al. (2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Milanski et al. (2009) 
4 week old Male 
Wistar Rats, 8 
week old 
C3H/HeN mice, 8 
week old 
C3H/HeJ mice 
Standard rodent chow (CD) (4.0 
g% or approx. 9% kcal), a high-
fat chow (HF) containing 36.0 g% 
fat (or approx. 56% kcal) from 
unspecified animal source, a 
unsaturated fat-rich chow (OL) 
containing 36.0 g% from olive oil 
 
Duration:  8 weeks for C3H/HeN 
and C3H/HeJ, 16 weeks for Male 
Wistar Rats 
 
In Male Wistar Rats 
 16 weeks of HF-feeding increased expression of TNF-α, IL-1β, IL-6, 
but not IL-10 in the hypothalamus 
 Increased cytokine expression was accompanied by increased F4/80 
expression in cells mostly present in the medial eminence and 
arcuate nucleus of the hypothalamus 
 Intracerebroventricular (ICV) injection of arachidic acid for 1 to 3 
days resulted in increased TLR-2/MyD88, TLR-4/MyD88 
associations, and levels of ER stress markers including UPR, pJNK, 
pPERK, and peIF2α  
 Most TLR-4 positive cells in the hypothalamus were found to be 
microglia cells expressing F4/80 
 TLR-4 inhibiting antibody completely restrained the capacity for 
ICV injection of arachidic acid to induce TNF-α, IL-1β, IL-6, and 
IL-10 expression 
In C3H/HeN and C3H/HeJ mice 
 HF-fed, C3H/HeN mice presented 50% body mass gain compared to 
30% body mass gain in HF-fed, C3H/HeJ mice 
 C3H/HeJ mice failed to induce a remarkable increase in IL-6 or IL-
10 expression after a 3 day ICV treatment of arachidic acid 
Granholm et al. 
(2008) 
16 month-old 
Male Fischer Rats 
12% soybean oil diet, “Sat-fat” 
diet consisting of 10% 
hydrogenated coconut oil and 2% 
cholesterol 
 
Duration:  8 weeks 
 “Sat-fat” fed rats committed more working memory errors in the 
radial arm maze, especially at higher memory loads 
 Increased microglial activation in the hippocampi of “Sat-fat” fed 
rats was observed through immunohistochemical staining 
Boitard et al. (2012) 3 week-old 
C57BL/6J, 12 
week-old 
C57BL/6J 
Standard chow diet consisting of 
3 g% from fat (approx. 6.5% 
kcal), high-fat diet (HFD) 
consisting of 45% kcal from fat 
(D#12451) 
 
Duration:  11 weeks 
 After 11 weeks of HFD-feeding, both weanling and adult C57BL/6J 
mice had similar morphometric and metabolic changes 
 Only HFD-fed weanling mice were impaired in both stages of the 
two-stage relational memory flexibility test 
 Only HFD-fed weanling mice had decreased neurogenesis as 
measured through doublecortin levels in the dentate gyrus of the 
hippocampus 
 Results indicate a critical period during development for HFD-
effects on hippocampus  
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Hwang et al. (2009) Weanling 
C3H/HeN mice, 
weanling 
C57BL/6N mice 
Low-fat diet (LD) consisting of 
10% kcal from fat, high-fat diet 
(HD) consisting of 60% kcal from 
fat 
 
Duration:  12 weeks 
 HD-fed C57BL/6N mice body weights and weight gains were 
significantly higher than LD-fed C57BL/6N, LD-fed C3H/HeN, or 
HD-fed C3H/HeN 
 C57BL/6N were more susceptible to HFD-induced lipid 
peroxidation in CA1 region of the hippocampus than C3H/HeN 
McNay et al. (2010) 1 month-old 
Sprague-Dawley 
Rats 
Standard lab chow, high-fat diet 
(HFD) consisting 31.8% kcal 
from butter and corn oil 
 
Duration:  14 weeks 
 HFD, in the absence of hyperinsulinemia or increased body mass, 
did not affect memory performance 
 Diet-induced obese rats showed impaired cognition compared to 
controls 
 Insulin injection into the hippocampus improved cognition in 
cognitively impaired rats 
Morrison et al. (2010) 20 month-old 
C57BL/6 from 
National Institute 
of Aging 
Low-fat control diets (98052602 
or D12450B), 
Western Diet (WD) (D12079B) 
consisting of 40% butterfat and 
29% sucrose, high fat lard diet 
(HFL) (D12492) consisting of 
60% animal fat 
 
Duration:  16 weeks 
 Both WD and HFL fed mice had increased body weight, adiposity, 
fasting blood glucose 
 Only HFL fed mice had increased age-related oxidative damage 
(protein carbonyls) and impaired retention in a behavioral test 
 Results implicated a potential role of an antioxidant enzyme, Nrf-2 
Puig et al. (2011) 6 week-old 
APP
tmlDbo
/J 
homozygous 
(APP 
-/-
) mice, 6 
week-old wild-
type C57BL/6J 
mice 
Low-fat diet (LFD) consisting of 
5.5% fat by weight (approx. 
11.6% fat by kcal), High-fat diet 
(HFD) consisting of 21.2% by 
weight (approx. 37.7% fat by 
kcal) 
 
Duration:  16 weeks 
 Adipose and brain tissue from HFD-fed mice had increased TNF-α, 
microglial (brain) or macrophage (adipose) activation 
 HFD-fed mice had increased APP proteins in brain and adipose 
 
Jeon et al. (2012) 4 week-old 
C57BL/6J mice 
Low-fat chow (LFD) consisting 
of 10% kcal from fat, High-fat 
diet (HFD) consisting of 60% 
kcal from fat (Diets from 
Research Diets) 
 
Duration: 20 weeks 
 HFD-fed mice had decreased serum adiponectin and glucose 
tolerance, and increased serum leptin, serum glucose, and serum 
insulin 
 HFD increased TNF-α and Iba-1 protein levels 
 HFD increased microglial activation in hippocampus  
 HFD increased 4-HNE levels compared to LFD-fed controls 
 HFD increased neurodegeneration in hippocampus 
Hwang et al. (2010) 3 week-old, 
weanling 
Normal chow consisting of 13.5% 
kcal from fat, High-fat diet (HFD) 
 Obese male mice developed hyperglycemia, hyperinsulinemia, 
hypercholesterolemia, and hyperleptinemia 
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C57BL/6J, both 
male and female 
consisting of 45% kcal from fat 
 
Duration:  9 to 12 months 
 Obese female mice had less hyperinsulinemia and 
hypercholesterolemia than obese males 
 Obese male mice had decreased learning performance than LFD-fed 
normal controls 
 Obese male mice had impaired synaptic plasticity compared to 
controls 
 Males were more vulnerable to HFD effects 
Farr et al. (2008) 8 week-old CD-1 
mice 
Regular chow (13.5% kcal from 
fat),  High-fat breeder chow (27% 
kcal from fat) 
 
Duration:  10 months 
 Obesity status was determined by 30% weight gain compared to 
regular chow controls 
 Obese mice showed impaired acquisition in 3 different cognitive 
paradigms:  active avoidance T-maze, Morris Water maze, and a 
food reward lever press 
 Intracerebrovascular (ICV) injection of triolein (triglyceride) caused 
significant cognitive impairment 
 ICV injection of palmitate did not significantly differ from saline 
control ICV injection 
 No differences were found in protein carbonyl levels or 3-
nitrotyrosine levels between mice on the 5 and 10% fat diets 
 ICV injection of gemfibrozil, a triglyceride lowering drug, improved 
cognition in impaired, obese mice 
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Appendix – Supplementary Data 
The following figures and table include additional PCR data collected throughout the 
course of this research project, a full breakdown of the dietary composition of the research 
diets, and additional serum ELISA data.  In addition to collecting the hippocampus, we 
conducted PCR on tissue from the brain stem and hypothalamus of the C3H mice.   
 In Table 3 and Table 4, a full breakdown of the dietary composition is listed for the 
study’s research diets (D12450B and D12451) as reported by ResearchDiets Inc. 
Table 3.  Fatty Acid Composition of LFD (D12450B) and HFD (D12451) from Research 
Diets 
Ingredient D12450B (low fat control) D12451 
Lard 20 177.5 
Soybean Oil 25 25 
Total Fat Added 45 202.5 
C2 – Acetic 0 0 
C4 – Butyric 0 0 
C6 – Caproic 0 0 
C8 – Caprylic 0 0 
C10 – Capric 0 0.1 
C12 – Lauric 0 0.2 
C14 – Myristic 0.2 2.0 
C14:1 – Myristoleic 0 0.0 
C15 0 0.1 
C16 – Palmitic 6.5 36.9 
C16:1 0.3 2.4 
C16:2 0 0 
C16:3 0 0 
C16:4 0 0 
C17 0.1 0.7 
C18 – Stearic 3.1 19.8 
C18:1 – Oleic 12.6 64.4 
C18:2 – Linoleic 18.3 56.7 
C18:3 – Linolenic 2.2 4.3 
C18:4 – Stearidonic 0 0 
C20 – Arachidic 0 0.3 
C20:1  0.1 1.1 
C20:2 0.2 1.4 
C20:3 0 0.2 
C20:4 – Arachidonic 0.1 0.5 
C20:5 – Eicosapentaenoic 0.2 0 
C21:5 0.0 0 
C22 – Behenic 0 0 
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C22:1 – Erucic 0 0 
C22:4 – Docosapentaenoic 0 0 
C22:6 – Docosahexaenoic 0 0 
C24 – Lignoceric 0 0 
C24:1 0 0 
Total 43.7 191.1 
Saturated (g) 9.9 60.0 
Monounsaturated (g) 13.0 68.0 
Polyunsaturated (g) 20.7 63.2 
Saturated (%) 22.7 31.4 
Monounsaturated (%) 29.9 35.6 
Polyunsaturated (%) 47.4 33.0 
 
Table 4.  Macronutrient and Micronutrient Composition of LFD (D12450B) and HFD      
(D12451) from Research Diets 
 
 D12451 D1240B 
Macronutrient gm% kcal% gm% kcal% 
Protein 24 20 19.2 20 
Carbohydrate 41 35 67.3 70 
Fat 24 45 4.3 10 
Total  100   
kcal/gm 4.73  3.85  
Ingredients gm kcal gm kcal 
Casein, 80 Mesh 200 800 200 800 
L-Cystine 3 12 3 12 
Corn Starch 72.8 291 315 1260 
Maltodextrin 10 100 400 35 140 
Sucrose 172.8 691 350 1400 
Cellulose, BW200 50 0 50 0 
Soybean oil 25 225 25 225 
Lard 177.5 1598 20 180 
Mineral Mix S10026 10 0 10 0 
DiCalcium Phosphate 13 0 13 0 
Calcium Carbonate 5.5 0 5.5 0 
Potassium Citrate, 1 H20 16.5 0 16.5 0 
Vitamin Mix V10001 10 40 10 40 
Choline Bitartrate 2 0 2 0 
FD&C Red Dye #40 0.05 0 0.05 0 
Total 858.15 4057 1055.05 4057 
 
Figures 12 – 19 include additional non-significant PCR data collected in the hippocampus of 
C57BL/6 and C3H mice, as well as PCR data collected in the brain stem and hypothalamus.  
Brain-stem and hypothalamus gene expression was assayed using the protocol previously 
described in Chapter 2.  Expression of pro-inflammatory cytokines including IL-1β, IL-6, 
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TNF-α, and IFN-γ, expression of the pro-inflammatory mediator, MIF, expression of an anti-
inflammatory cytokine, IL-10, and expression of anti-inflammatory mediatory, SOCS-3, 
were all assayed.  Of particular note, MIF expression was decreased in the hypothalamus of 
HFD-fed C3H/HeN mice compared to LFD controls.  There were no other significant 
differences in expression of any of the genes assayed in C3H or C57BL/6 mice. 
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Figure 12.  IL-1β expression, IL-6 expression, MIF expression, and SOCS-3 expression in the hippocampus of C57BL/6J mice fed 
8 weeks of either LFD or HFD.  Data are means ± SEM.  *difference from LFD control, P < 0.05.  
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Figure 13.  IL-10 expression, IFN-γ expression, MCP-1 (CCL-2) expression, MIP-1α (CCL-3) expression, and RANTES (CCL-5) 
expression in the hippocampus of C3H mice fed 8 weeks of either LFD or HFD.  Data are means ± SEM.  *difference from LFD 
control, P < 0.05.  
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 Figure 14.  IL-1β expression, IL-6 expression, TNF-α expression, IFN-γ expression, and MIF expression in the brain stem of C3H 
mice fed 8 weeks of either LFD or HFD.  Data are mean ± SEM.  *difference from LFD control, P < 0.05. 
 77 
 
 
Figure 15.  MCP-1 (CCL-2) expression, MIP-1α (CCL-3) expression, and RANTES 
(CCL-5) expression in the brain stem of C3H mice fed 8 weeks of either LFD or HFD.  
Data are mean ± SEM.  *difference from LFD control, P < 0.05. 
  
 
7
8 
Figure 16.  IL-10 expression and SOCS-3 expression in brain stem of C3H mice fed 8 weeks of either LFD or HFD.  Data are 
mean ± SEM.  *difference from LFD control, P < 0.05. 
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Figure 17.  IL-1β expression, IL-6 expression, TNF-α expression, IFN-γ expression, and MIF expression in hypothalamus of C3H 
mice fed 8 weeks of either LFD or HFD.  Data are mean ± SEM.  *difference from LFD control, P < 0.05. 
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Figure 18.  MCP-1 (CCL-2) expression, MIP-1α (CCL-3) expression, and RANTES 
(CCL-5) expression in the hypothalamus of C3H mice fed 8 weeks of either LFD or HFD.  
Data are mean ± SEM.  *difference from LFD control, P < 0.05. 
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Figure 19.  IL-10 expression and SOCS-3 expression in hypothalamus of C3H mice fed 8 weeks of either LFD or HFD.  Data are 
mean ± SEM.  *difference from LFD control, P < 0.05. 
 
 82 
 
In addition to PCR data, serum Resistin, represented in Figure 20, was also measured 
through ELISA (R & D systems) as previously described in Chapter 2. 
 Figure 20.  Serum Resistin of fed C3H mice after 8 weeks of either LFD or HFD feeding.  
Data are mean ± SEM.  Labeled means without a common letter differ, P < 0.05. 
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